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Eukaryotic ribosome biogenesis, a dynamic and coordinated multistep process 
which requires more than 150 trans-acting factors, has been intensely studied in the yeast 
Saccharomyces cerevisiae. This evolutionarily conserved process involves numerous 
cleavages of pre-rRNA, modification of nucleotides, and concomitant assembly of the 
ribosomal proteins onto the rRNA. Considerable information is available about the 
importance of conserved pre-rRNA cleavage events in ribosome biogenesis; however, very 
little is known about the exact role of modified nucleotides, which cluster within the 
functionally important regions of the ribosome. One conserved group of modifications is 
x 
the dimethylation of two adjacent adenosines at the 3´ end of the small subunit rRNA 
which is ubiquitously carried out by the Dim1/KsgA methyltransferase family. Although 
dimethylation and KsgA are dispensable for survival in bacteria, the eukaryotic enzyme 
Dim1 is essential because of its requirement in the early pre-rRNA processing events. 
Similarly, few other members of the family have also evolved to carryout a second 
unrelated function in the cell. Almost all of the information about Dim1 was obtained from 
in vivo experiments in yeast, and has been determined that it is an indispensable part of a 
RNA-protein complex carrying out the pre-rRNA processing. Sequence analysis clearly 
shows that eukaryotic and archaeal enzymes have an extra insert in their C-terminal 
domain which is absent in bacterial enzymes and a better understanding of Dim1’s 
function is only possible by its structural characterization which is the aim of this study.  
After several attempts, the yeast Dim1p was expressed under mild conditions in E. 
coli and purified in soluble form. Dim1p was able to methylate bacterial 30S subunits both 
in vivo and in vitro, indicating its ability to recognize bacterial substrate. Supporting our 
hypothesis, neither the bacterial nor archaeal orthologs were able to complement the 
processing function of Dim1p in yeast, tested using the plasmid shuffling technique. Our 
results suggest that the C-terminal insert of Dim1p, along with some structural features of 
the N-terminal domain, is important for its function in pre-rRNA processing. Further 
studies are required to understand the complex interactions between proteins and RNA 
involved in the ribosome biogenesis.    
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CHAPTER 1: Introduction 
 
Ribosome Biogenesis in Eukaryotes 
The ribosome is the enzyme essential for protein synthesis and is among the most 
fundamental molecular machines in all cells. Bacterial ribosomes have also been exploited 
therapeutically for more than 60 years in the pharmaceutical industry and continue to be a 
validated target for anti-infective agents. Hence, there has been a constant enthusiasm to 
study its structural, functional and biogenetic aspects in detail.   
Ribosomes consist of two unequal subunits; large subunit (50S/60S) and small 
subunit (30S/40S) in prokaryotes/eukaryotes, respectively. Their synthesis involves 
transcription of rRNA, pre-rRNA processing, modification and simultaneous assembly of 
ribosomal proteins. Although prokaryotic and eukaryotic ribosomes have similar 
architecture and carryout the same function, there are significant differences in their 
biogenesis with the pathway being more complicated in eukaryotes than prokaryotes. This 
work is focused on the biogenesis of small subunit, specifically a conserved dimethylation 
of two adjacent adenosines observed in the small subunit rRNA and the conserved enzyme 
family carrying out the process.   
Eukaryotic ribosome biogenesis, a dynamic and coordinated multistep process 
which requires more than 150 trans-acting factors, has been intensely studied in the yeast 
Saccharomyces cerevisiae and extensively reviewed1-7. It is also a costly demand for the 
2 
cell, considering the amount of cellular metabolites and energy that it utilizes8. Eukaryotic 
ribosomes contain a copy of each of the four ribosomal RNAs; 5S, 5.8S, 18S, and 25/28S 
(yeast/ higher eukaryotes) rRNA and about 75 different ribosomal proteins. All three 
transcription machineries (RNA polymerases I, II and III), are utilized to ensure the high 
efficiency and accuracy of ribosome production. Pol I transcribes 25S/28S, 5.8 and 18S 
rRNA, Pol III synthesizes 5S rRNA, whereas Pol II transcribes the mRNAs for the 
ribosomal proteins.  
In eukaryotes, ribosome synthesis starts in the nucleolus, the specialized nuclear 
compartment which is also the site of rRNA transcription and most maturation steps.   The 
basic organization of the eukaryotic rRNA operon is similar in all species and the yeast 
rDNA unit is shown in Figure 1. The yeast rDNA unit is 9.1 kb long and present in 100 to 
200 head-to-tail copies on chromosome XII. It consists of the 35S pre-rRNA operon and 
two nontranscribed spacers, NTS1 and NTS2, interrupted by the 5S rRNA gene. The 35S 
pre-rRNA operon contains the sequences for the mature 18S, 5.8S, and 25S rRNAs 
separated by the two internal transcribed spacers, ITS1 and ITS2, and flanked at either end 
by two external transcribed spacers, the 5´-ETS and 3´-ETS. RNA polymerase I transcribes 
the entire 35S pre-rRNA whereas 5S rRNA gene is transcribed in the opposite direction by 
RNA polymerase III.  
As soon as the transcription of 35S rRNA is completed, the transcript is processed 
to remove the spacers by endo- and exoribonucleases and extensively modified, mainly by 
pseudouridylation (ψ) and 2´-O-ribose methylation (CH3) which are guided by small 
ribonucleoprotein particles (snoRNPs). More than 150 of such non-ribosomal trans-acting  
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Figure 1:  Structure and processing of pre-rRNA in Saccharomyces cerevisiae. (A) shows 
the yeast rDNA unit, 35S pre-rRNA operon and specified processing sites. (B) Processing 
of the 35S precursor to the mature rRNA species. 
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factors5,9 are involved in these processing and modification events which are probably 
preceded and accompanied by the assembly of r-proteins10, forming large RNP particles. 
Many components involved in the complex steps of ribosome formation have been 
identified and characterized in the yeast Saccharomyces cerevisiae, owing to its excellent 
genetic and biochemical suitability. Therefore, budding yeast has become an attractive 
‘model organism’ to study many aspects of eukaryotic ribosome biogenesis.  
The pathway by which the primary 35S precursor is processed into the mature 18S, 
5.8S, and 25S rRNA is depicted in Figure 1. The earliest processing site is at A0 in the 5'-
ETS, 90 nucleotides upstream of the 5' end of mature 18S rRNA. Processing at A0 yields 
the 33S pre-rRNA, which is rapidly cleaved at site A1, producing the 32S pre-rRNA. 
Cleavage at A2 in ITS1 then splits the 32S pre-rRNA into the 20S and 27SA2 pre-rRNAs, 
which are destined to form the mature species of the small and large ribosomal subunit, 
respectively. The 5' part of the molecule, 20S pre-rRNA, is exported to the cytoplasm 
where it is cleaved at site D leading to the mature 18S rRNA. Processing of the 27SA2 pre-
rRNA, occurs by two alternative pathways yielding mature 5.8S and 25S rRNAs.  
 
90S Pre-ribosome and SSU processome 
As the 35S rRNA is transcribed, several factors including snoRNAs, ribosomal and 
non-ribosomal proteins associate with it, co- and post-transcriptionally, to form a 90S 
particle in the nucleolus. It is the first and largest pre-ribosomal particle identified by its 
sedimentation characteristics. After initial processing events at sites A0, A1, A2, it is 
cleaved into 66S and 43S particles, the precursors to the 60S and 40S subunits (Figure 2).  
5 
             
Figure 2: Ribosome biogenesis in Saccharomyces cerevisiae. Dim1 binds to the 90S pre-
ribosome very early, in the nucleolus and remains associated until the late cytoplasmic 
stage. Base dimethylation is the penultimate step in 40S subunit biogenesis.  
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Accordingly, it was initially thought to contain the synthetic machinery of both 40S and 
60S subunits, however, it was recently found that 90S pre-ribosome predominantly 
includes 40S subunit processing factors11. Along with the 35S rRNA, 90S precursor 
contains U3 snoRNA, proteins associated with U3, and factors required for 18S rRNA 
synthesis, but only a few 60S processing factors. This discovery and further analysis of 
pre-ribosomal particles were made possible by the development of efficient purification 
protocols, especially the ‘tandem affinity-purification’ (TAP) method12, combined with 
sensitive methods such as mass spectroscopy to identify the associated proteins.  
 Another breakthrough in the study of ribosome biogenetic pathway was obtained 
from the analysis of pre-rRNA transcripts by Miller chromatin spreads13,14. The technique 
helped in the observation of growing pre-rRNA transcripts by electron microscopy. 
Observations made in the 1970s suggested that the pre-rRNA processing machinery 
assembles co-transcriptionally onto the nascent transcripts and forms the ‘terminal knobs’ 
at the 5′ end of each 35S pre-rRNA molecule which were considered as the growing 90S 
pre-ribosomes. It was thought that the 90S pre-ribosome splits in to 66S and 43S particles 
only after the transcription of 35S pre-rRNA is completed15-17. The appearance of the 35S 
primary rRNA transcript when the pre-rRNAs are analyzed by both northern blot and 
pulse-chase analysis also indicated that the cleavage in ITS1 occured after completion of 
transcription of the entire gene. Contrary to this long-held view, the Beyer, Baserga and 
Dragon groups have recently shown that the processing of the yeast pre-rRNA does often 
occur before the completion of transcription18. The yeast chromatin spreads (Miller 
spreads) revealed that in cells growing exponentially under optimal growth conditions, the 
7 
co-transcriptional cleavage of pre-rRNA in ITS1 was observed in 55% of the transcripts, 
thereby separating the pre-rRNAs destined for the small and large subunits. However, 
neither co-transcriptional nor post-transcriptional cleavage in ITS1 is obligatory for further 
events. 
Summarizing the above information, a predominantly 40S processing machinery 
assembles co-transcriptionally beginning at the 5´ end and forms the ‘knobs’ at the 
growing end of 35S pre-rRNA. The components of these initial ‘terminal knobs’ are 
essential for cleavages at sites A0-A2 and hence designated as the small subunit (SSU) 
processome1,3,18,19. In a slight majority of the transcripts co-transcriptional cleavage occurs 
in ITS1 separating the 18S rRNA as a 43S particle from the growing strand. Few 60S 
processing factors would then start associating with the remaining strand containing 5.8S 
and 25S rRNA and form small particles at the new 5´ end, termed as large subunit (LSU) 
knobs18,20 (Figure 3). In transcripts where the co-transcriptional cleavage does not occur, 
the mature 90S precursors formed at the end of transcription undergo cleavage in ITS1 to 
release 43S particle and pre-60S particle. 
After the cleavage in ITS1, many of the factors including U3 snoRNA and its 
associated proteins are released from the 43S particles rapidly leaving behind a relatively 
elementary pre-40S particle with only a few non-ribosomal components21. These core 
factors characterized in yeast (Enp1p, Dim1p, Dim2p, Hrr25p and Rrp12p) are detected 
even in the earliest SSU processome/ 90S pre-ribosomes. Other factors (Nob1p, Rio2p and 
Tsr1p) appear to bind later to more advanced pre-40S particles, possibly after A0–A2 
cleavages but before nuclear exit. The pre-40S subunits are then transported through the  
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Figure 3: Co-transcriptional processing of S. cerevisiae rRNA transcripts. Schematic of 
rRNA gene is shown at the top. The region before A2 site is colored red and the region after 
A2 is in blue. Co-transcriptional A2 cleavage is observed in slight majority of the 
transcripts (55 %) which releases the ‘SSU knob’, shown as red circles. Alternatively, the 
90S pre-ribosome are cleaved post-transcriptionally to give the 43S and 66S particles. 
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nucleoplasm and the nuclear pore complex to the cytoplasm, where final maturation events 
occur including a pre-rRNA processing event to produce 18S rRNA from 20S pre-rRNA22. 
The few factors that remain associated with the late 40S pre-ribosomes are involved in the 
final maturation of 40S subunits and are released gradually during these final stages. 
The pre-60S maturation, in contrast to pre-40S maturation, is more complicated and 
includes several well characterized nucleoplasmic and cytoplasmic intermediates1,22. The 
pre-60S particles released after the end of transcription as the LSU knobs or following the 
cleavage of 90S particle have fewer non-ribosomal factors. Immediately after their release, 
more than 50 non-ribosomal proteins associate with these earliest nucleolar pre-60S 
ribosomes, which then undergo enormous reengineering on their path from the nucleolus to 
the cytoplasm23. During the movement from the nucleolus towards the nuclear pore, many 
of the factors disassemble from the pre-60S precursors in sequential steps, whereas a few 
proteins associate transiently at later stages (Figure 2). After export to the cytoplasm, only 
few factors are left on the pre-60S subunits which are released after the final maturation 
steps.  
Ribosome biogenesis in higher eukaryotes is very similar to that of yeast. Many of 
the non-ribosomal factors have homologs in vertebrates and have been found in 
mammalian pre-ribosomes24,25.   
 
Ribosome biogenesis in Prokaryotes 
Prokaryotic ribosome biogenesis is relatively simpler in contrast to the eukaryotic 
process. The mature rRNAs (23S, 5S and 16S) in prokaryotic ribosomal subunits are 
10 
synthesized as a single transcript with additional intervening and flanking regions of RNA 
(including tRNA). The pre-rRNA transcript is then processed to obtain the mature rRNAs 
and this process involves several non-ribosomal factors and RNases26. Several of these 
factors have good sequence homology with that of eukaryotes. Similar to eukaryotes, the 
processing, modification of nucleotides and the association of ribosomal proteins occur co-
transcriptionally on the pre-16S rRNA. However, the order of pre-16S processing and 30S 
subunit assembly events is still largely unknown. Much of the current understanding about 
30S subunit assembly resulted from in vitro studies that demonstrated that functional 30S 
subunits could be reconstituted in vitro from a mixture of 30S subunit proteins and purified 
16S from E. coli27. During the in vitro reconstitution, a 21S particle was obtained at low 
temperatures (0 to 15˚C) and it was designated as Reconstitution Intermediate (RI)28-30. A 
corresponding analog of the RI was also observed in the in vivo assembly pathway31,32, 
supporting the in vitro reconstitution experiments. The RI undergoes a rate-limiting 
conformational rearrangement in the folding of 16S rRNA, yielding a more compact 26S 
particle, designated as RI*. In vitro, this high activation energy barrier is overcome by 
heating RI to 42˚C, while in vivo, this step likely requires chaperones33. In both cases, once 
this barrier is crossed the remaining ribosomal proteins readily assemble, even at low 
temperature. Assembly maps have also been similarly constructed for the 50S subunit34,35. 
 
Nucleotide Modification  
The pre-rRNA processing and subunit assembly events are accompanied by 
modification of nucleotides, another important process observed in all forms of life. The 
11 
nucleotide modifications are of three main types; conversion of uridine to pseudouridine 
(ψ), 2'-O-ribose methylation, and alterations to bases, most of which undergo methylation 
at different positions.  The number of modified sites increases with the complexity of the 
organism, with Escherichia coli having 11 pseudouridines, 4 ribose methylations, and 19 
base methylations; Saccharomyces cerevisiae have 44 pseudouridines, 55 ribose 
methylations and 10 base methylations; Homo sapiens have 91 pseudouridines, 105 ribose 
methylations and 10 base methylations36,37. The modification patterns show some 
evolutionary conservation with a distinct clustering in regions implicated in ribosomal 
function38-40, and most sites modified in the yeast rRNA are also modified in vertebrates. 
Current values for the archaea range substantially depending on the temperature at which 
they are grown, with some having considerably more pseudouridines and ribose 
methylations than bacteria41.  
Modifications in E. coli are mediated by site-specific protein enzymes such as 
ribose methylases or pseudouridine synthases, without the involvement of a RNA guide 
component42,43. By contrast, the pseudouridylations and ribose methylations in eukaryotes 
are carried out by two families of site-specific, small nucleolar RNA–protein complexes 
(snoRNPs). Members of one family, box H+ACA snoRNPs, are responsible for 
pseudouridylations and the other, box C+D snoRNPs, are responsible for 2′-O-ribose 
methylations. In both processes, the sites for modification are selected by the RNA 
component (different guide snoRNAs belonging to box C+D and box H+ACA classes) 
through base pairing with a conserved sequence, and catalysis is mediated by a type-
specific protein component7,44. The archaea use a similar C+D snoRNP for ribose 
12 
methylation45 and proteins related to those in the H+ACA snoRNPs have also been 
identified46. 
In contrast to the 2'-O-ribose methylation and pseudouridine formation, base 
methylation is mediated by specific protein enzymes without any involvement of guide 
snoRNAs. The most well characterized among these is the dimethylation of two adjacent 
adenosines localized in the loop of the 3´-terminal helix (helix 45 in Escherichia coli) of 
small subunit rRNA (Figure 4). This region is one of the most highly conserved sequences 
in the small subunit rRNA47,48. Interestingly, this dimethylation is also highly conserved in 
all organisms from prokaryotes to vertebrates, including organelles such as mitochondria 
and chloroplasts with respect to the number of methyl groups added and their position on 
the small subunit rRNA49. Even the enzymes carrying out this dimethylation are also 
universally conserved, belonging to the Dim1/KsgA family of methyltransferases (referred 
as Dim1p in Yeast).  
The dimethylation of two adjacent adenosines is a late event in the biogenetic 
pathway. In eukaryotes, it occurs on the cytoplasmic pre-40S particles50 and in 
prokaryotes, the modification occurs on a late intermediate, most probably a 26S particle51. 
In contrast, most of the sno-RNA directed pseudouridylations and ribose methylations 
occur very early. In eukaryotes, some of them occur co-transcriptionally during the 
formation of SSU processome, on the 35S pre-rRNA transcript18,37,52,53 and the remaining 
occur soon after the cleavage at site A2.  
The effect of nucleotide modification on rRNA is one of the oldest questions in 
RNA science and information is still limited. Their effects include altered steric properties 
13 
  
Figure 4: (a) Secondary structure of S. cerevisiae 18S rRNA. The universally conserved 3´ 
terminal helix is circled in blue. (b) conserved adenosines (1779 and 1780) in the helix. 
14 
in all cases, different hydrogen-bonding potential, enhancement of local base stacking 
(pseudouridylation) and increased structural rigidity for both single- and double-stranded 
regions (pseudouridylation and 2'-O-methylation)54,55. Methylation of 2′-OH favours the 3′ 
endo configuration and prevents hydrolysis of internucleotide bonds56. Although most of 
the modified nucleotides cluster within the functionally important regions of the 
ribosome38, so far, no single rRNA modification has been found to be essential for 
ribosome function57-60. However, when the pseudouridylations and 2'-O-methylations were 
blocked on a global level, strong negative effects were observed on the yeast growth61,62. 
Similarly, eubacterial subunits reconstituted with unmodified RNA are active in peptide-
bond synthesis but have much less activity than subunits reconstituted with natural 
rRNA59,60,63. Thus, it seems probable that most individual modifications contribute a small, 
non-essential benefit and that, in aggregate, a large benefit is provided by the full ensemble 
of modifications. Interestingly, modifications are essentially absent from areas dominated 
by ribosomal proteins: the external surfaces and periphery of the interface regions38. So the 
rRNA modifications might act as a molecular mortar to stabilize the required RNA 
conformations64 and fine-tune the translation process65-67 or they might play a role in 
‘building’ the vital domains of the subunits properly, rather than a direct involvement in 
the chemistry or structural changes associated with the translation process. 
Similarly, though the dimethyladenosines in the 3´-terminal helix of small subunit 
rRNA have been universally conserved, a distinct cellular function could not be ascribed 
yet. However, in eukaryotes the conserved modifying enzyme is essential for survival 
because of its role in another process.  
15 
Dim1 
The Dim1/KsgA family belongs to a well-characterized group of S-adenosyl-L-
methionine (SAM) dependent methyltransferases (also known as AdoMet dependent 
MTases) which includes DNA, RNA, protein and small molecule methyltransferases68. All 
the enzymes in this group have a characteristic Rossman-like fold in their SAM binding 
domain, which consists of a central β-sheet surrounded by a variable number of α-helices, 
and they share several conserved motifs69,70. Many of these AdoMet dependent 
methyltransferases have been well characterized structurally and biochemically, and their 
mechanisms have been explored. While most of the methyltransferases transfer a single 
methyl group onto their target, the members of Dim1/KsgA family, with a very few 
exceptions, transfer two methyl groups onto the exocyclic nitrogen of each of the two 
adjacent adenosines (A1779, A1780 in Saccharomyces cerevisiae and A1518, A1519 in 
Escherichia coli). This reaction consumes four molecules of the co-factor (SAM) which is 
then converted to S-adenosyl-homocysteine (Figure 5). This process also requires the 
target adenosine bases facing the inner side of the loop to ‘flip out’, in order to be 
methylated by the enzyme. This process has been extensively studied in DNA 
methyltransferases, whose target bases reside within the double helix71, 72. 
In eukaryotes, Dim1 is not important for its methyltransferase function, but for an 
indispensable role in pre-rRNA processing in the early steps of ribosome biogenesis. The 
putative yeast 18S rRNA dimethylase gene, DIM1, was originally identified by its ability 
to dimethylate the E. coli 16S rRNA in vivo and restore the kasugamycin sensitivity of the 
ksgA mutant of E. coli73. Further functional characterization of the DIM1 gene has been  
16 
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Figure 5: The adenosine dimethylation. During the reaction, two molecules of the co-factor 
(SAM) are consumed for each adenosine.   
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carried out in yeast where the encoded protein is referred as ‘Dim1p’, based on the yeast 
nomenclature, in contrast to ‘Dim1’ in other eukaryotes. The DIM1 gene is present in 
chromosome XVI between the coordinates 39121-40077, and has a systematic name 
“YPL266W”.  
Lafontaine et al. showed that the genetic depletion of Dim1p not only blocked the 
dimethylation of the pre-rRNA but also strongly inhibited the nucleolar pre-rRNA 
processing steps at cleavage sites A1 and A274. Cleavage at site A1 gives rise to the mature 
5′ end of 18S rRNA and cleavage at site A2 separates the pre-rRNAs destined for the small 
and large ribosomal subunits. Inhibition of these cleavages results in the accumulation of 
33S pre-rRNA formed after 35S pre-rRNA is cleaved normally at site A0. The 33S pre-
rRNA is then cleaved at site A3 by RNase MRP75 which is not affected by the inhibitions at 
A1 and A2. This results in the release of an aberrant 22S pre-rRNA extending from A0 to A3 
that is neither dimethylated nor can be processed to 18S rRNA inhibiting the formation of 
40S subunits (Figure 6). However, cleavage at A3 also produces the 27SA3 precursor that is 
normally processed to 5.8S and 25S rRNAs and hence the maturation of 60S subunits is 
unaffected.   
It was later demonstrated that the enzymatic function of Dim1p in dimethylation 
can be separated from its involvement in pre-rRNA processing50. Lafontaine et al. have 
isolated a yeast strain, dim1-2, from a library of conditionally lethal alleles of DIM1, in 
which pre-rRNA processing was not affected at the permissive temperature for growth, but 
dimethylation was blocked, leading to accumulation of nondimethylated 18S rRNA. This 
proved that the processing defect is a consequence of the absence of Dim1p and not the 
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Figure 6: Effects of Dim1p depletion on pre-rRNA processing. 33S pre-rRNA accumulates 
due to the inhibition of cleavages at sites A1 and A2. It is cleaved at site A3, providing the 
27SA3 that is normally processed to 5.8S and 25S rRNA. Cleavage at site A3 also produces 
the aberrant 22S pre-rRNA extending from site A0 to A3, that cannot be processed to 18S 
rRNA.  
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dimethylated adenosines. This is also in agreement with the fact that dimethylation is a late 
event occurring on the cytoplasmic 20S rRNA precursor, whereas the processing events 
are the early steps occurring in the nucleolus. Although the dimethylation is not essential 
for survival of yeast, the two adenosines are not dispensable. Replacement of adenosines 
by guanosines failed to support yeast growth74.  
Interestingly, another factor, Dim2p (also referred as RRP20 and PNO1), was also 
found to be essential for the A1, A2 cleavages and for the dimethylation carried out by 
Dim1p76,77. Dim2p has a conserved KH-domain which is a well characterized RNA 
binding domain78 and is also a core constituent of the SSU processome complex. 
Association of Dim2p with the 35S and methylated 20S pre-rRNAs indicated that the 
protein joins the preribosomes at an early nucleolar stage and follows the particles to their 
site of final maturation in the cytoplasm11,21. The association between Dim1p and Dim2p 
was tested by coprecipitation76, and it is thought that Dim2p associates with Dim1p during 
the processing and dimethylation events. Information from the recent high-throughput 
copurification data sets79-81 revealed that Dim2p also associates with Nob1p, Rio2p, Tsr1p, 
Utp18p and Utp22p (the last two are U3-snoRNA associated proteins).  
Schafer et al. showed that after the A2 cleavage, most of the SSU processome 
factors leave the 40S precursor but a few factors which include Dim1p, Dim2p, Enp1p, 
Hrr25p remain associated with the pre-40S particle21. Few other factors such as Nob1p, 
Rio2p, Tsr1p appear to associate with pre-40S only after the rRNA cleavage at site A2. 
Based on the above processing events and composition of pre-ribosomal particles, it can be 
summarized that Dim1p, Dim2p are among the core constituents of the SSU processome 
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complex along with U3 snoRNP and other factors that assemble co-transcriptionally on to 
the pre-rRNA transcript. The 5'-ETS region is highly structured, with the cleavage sites A0 
and A1 in close proximity at opposite sides and near the base of an extended stem-loop 
structure82. Interestingly, site A2 in ITS1 is also positioned before a stem-loop structure83.  
It is widely believed that cleavage at sites A1 and A2 is coupled as mutations or 
depletions of many different trans-acting factors, including Dim1 and Dim2, apparently 
resulted in the simultaneous inhibition of both of them7, but A0 cleavage is not obligatorily 
coupled to the other two84. This assumption is supported by the fact that U3 snoRNA, 
which base-pairs to the pre-rRNA in the 5′ ETS region85,86, is also essential for A2 along 
with A0 and A1. Although the binding site of Dim1p and Dim2p is not known, they 
probably associate near the 3´ end of 18S rRNA region and interact with other factors and 
snoRNPs forming a large complex (SSU processome) in which the cleavage sites are 
brought closer6,7 (Figure 7). This may resemble the situation in E. coli where the 5′ and 3′ 
ends of 16S rRNA are brought together by base pairing of sequences present at either end. 
Processing at sites A0, A1, and A2 are endonucleolytic events, as the spacer fragments 
released by these steps (A0-A1, D-A2 and A2-A3; see Figure 1) could be detected87,88. 
Although the enzyme/s responsible for the cleavages has not yet been identified, it is 
possible that they are cleaved by the same endonuclease based on the presence of similar 
recognition signals6,7.  
After the A1 and A2 cleavages, most of the factors and snoRNPs leave the pre-40S 
particle except a few which include Dim1p, Dim2p, Enp1p and Hrr25p, and during the 
same time few more factors such as Nob1p, Rio2p, Tsr1p and Ltv1p associate with the  
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Figure 7: Coupling of cleavage at sites A1 and A2. The 5´ and 3´ ends of 18S rRNA are 
brought together by the snoRNPs and factors of the SSU processome complex (blue ovals). 
The existence of similar recognition signals near the sites A1 and A2 raises the possibility 
that both sites might be cleaved by the same endonulease. 
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particle. However, the order of dissociation or association of these factors is not clearly 
known. Some of the factors such as Ltv1p, Rio2p, Tsr1p and Enp1p are required for the 
nuclear export of 40S subunits. In the cytoplasm, the pre-40S particle undergoes a few 
additional maturation steps. Schafer et al. reported that Hrr25p-dependent phosphorylation 
of an Enp1p/Ltv1p/Rps3p subcomplex, followed by dephosphorylation by an unknown 
phosphatase, is required for proper incorporation of Rps3p into the 40S subunit and correct 
formation of a ‘beak’ structure close to the head of the 40S subunit89. This also results in 
the dissociation of Enp1p, Ltv1p and Hrr25p from the pre-40S particle. The dimethylation 
of 20S pre-rRNA at residues A1779 and A1780 is carried out by Dim1p in association with 
Dim2p. The order of these two events is not clearly known or they might occur 
simultaneously. However, it is interesting to note that Dim1p methylates the pre-40S 
particle near the final stages of maturation, although it binds to the pre-rRNA in the 
nucleolus. It is possible that the target adenosines are oriented in the right position that 
facilitates the methylation, only after some conformational rearrangements occur in the 
pre-40S particle involving other factors and ribosomal proteins. Finally, the 
endonucleolytic processing of 20S pre-rRNA to 18S rRNA at cleavage site D occurs, 
which is most probably catalyzed by Nob1p90,91. Recently, Granneman et al. proposed that 
a putative NTPase, Fap7, mediates this cleavage by directly interacting with Rps1492. 
Although it is not clearly known which protein is actually implicated in the cleavage, 
Nob1p appears to be the likely candidate as it contains the characteristic PIN domain. 
Interestingly, Nob1p has been shown to associate with Dim2p in the maturation of the 20S 
proteasome93. Factors such as Tsr1p, Rio2p are also involved in 3′-end formation of mature 
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18S rRNA94,95. The order in which the processing factors dissociate from the 40S subunit 
is not clearly known. Similarly, it is also not clearly known if Dim1p and/or Dim2p remain 
associated to the 40S subunit until the cleavage at site D has occurred or dissociate 
immediately after the dimethylation event.  
 
Dim1/KsgA family      
As mentioned earlier the dimethylated adenosines are conserved across kingdoms 
including cell organelles. The Dim1/KsgA methyltransferase family has nuclear encoded 
orthologs that are localized into the chloroplasts96 and mitochondria97. The only known 
exceptions are in Saccharomyces cerevisiae mitochondrial 12S rRNA, which has no 
methyl groups on the two adenosine bases98; Euglena gracilis chloroplast rRNA99 and the 
16 S rRNA of the archaebacterium Sulfolobus solfataricus41, both of which have only one 
dimethylated adenosine base. 
The Dim1 ortholog in bacteria, first identified as KsgA100 carries out the 
corresponding dimethylation on A1518 and A1519 and has been named after its phenotype. 
Interestingly, knockout of KsgA in bacteria, resulting in the loss of methyl groups, confers 
resistance to the aminoglycoside antibiotic kasugamycin101,102, with only marginal effects 
on growth103-105. Kasugamycin (Ksg) specifically inhibits translation initiation of 
canonical, but not of leaderless, messenger RNAs. Ksg binds within the messenger RNA 
channel of the 30S subunit and forms hydrogen bonds with the universally conserved G926 
and A794 nucleotides in the 16S rRNA106-108. Lack of dimethylation at A1518 and A1519 
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results in conformational changes which indirectly alter the Ksg binding site and confer 
resistance to the drug.   
Apart from the dimethylation, the members of Dim1/KsgA family have evolved to 
carryout other functions in the cell, which is clearly evident in eukaryotic Dim1. Recently 
it has been shown that KsgA is also involved in pre-rRNA processing in E.coli. Knockout 
of KsgA leads to a processing defect resulting in the accumulation of immature small 
subunit rRNA (Connolly K, Rife JP, Culver GM, unpublished results). However, this 
processing defect is not detrimental, as functional 30S subunits could still be formed. Pfc1, 
the Dim1 ortholog in chloroplast has also been found to be important for proper 
development of chloroplast at low temperatures96.  
The Dim1 ortholog in eukaryotic mitochondria, referred as mtTFB, serves as a 
mitochondrial transcription factor as well as being the dimethyltransferase for 
mitochondrial 12S rRNA97,109. Similar to Dim1, it has been found that the methylation 
activity of human-mtTFB can be separated from its transcription activity110. h-mtTFB also 
has an intriguing link with human disease, having been shown to be a phenotypic modifier 
of deafness associated with a polymorphic A1555G mutation in mitochondrial rRNA111,112.  
The Erm family of methyltransferases is another group of enzymes homologous to 
Dim1/KsgA family and they mediate resistance to the macrolide-lincosamide-
streptogramin B (MLS-B) group of antibiotics in bacteria113,114. The Erm enzymes have, 
probably, descended from one or more bacterial KsgA genes and evolved to recognize a 
completely different RNA substrate while keeping essentially the same function. The Erms 
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mono- or dimethylate a single adenosine base of 23S rRNA, near the peptidyl transferase 
site of the 50S subunit115.  
 
Objectives  
The Dim1/KsgA family of methyltransferases is interesting in two aspects; not only 
are they universally conserved but also evolved to carryout other cellular functions. 
Although the sequence homology among members of the same domain is high, the 
homology is relatively low across the domains. The sequence homology between yeast 
Dim1p and bacterial KsgA is ~25%, but the homology between yeast and human Dim1 is 
as high as 80%. This could be attributed to the eukaryotic enzyme’s indispensable 
secondary function in pre-rRNA processing and hence mutations in the enzyme were less 
tolerated during evolution. Secondly, the homology between KsgA and Dim1 is high only 
in the SAM binding domain, but very poor in the other regions.  
At the onset of this project, the crystal structure of E. coli KsgA had been solved in 
our laboratory70. The crystal structures of sc-mtTFB116 and ErmC′117 have also been solved 
earlier by other groups. While these structures can be beneficial to studies of the KsgA 
family of enzymes in prokaryotes, they are of limited usefulness in answering detailed 
questions about structure/function relationships in eukaryotes. Strikingly, eukaryotic and 
archaeal enzymes have a long insert in their C-terminal domain which is absent in 
prokaryotic enzymes and this could be important for the processing function of Dim1. 
Almost all of the information regarding Dim1 has been obtained from in vivo studies in 
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yeast50,73,74 and in order to dissect the structural elements relating to its functions, structural 
characterization is required.  
After several attempts, soluble Dim1p was purified and it was able to methylate 
bacterial 30S subunits in vitro in compliance with the in vivo data. During the course of 
this work the crystal structures of human Dim1 (1ZQ9) and that of Plasmodium falciparum 
(2H1R) became available (Dong et al., Structural Genomics Consortium). Utilizing the 
information from the crystal structures of KsgA and human-Dim1, further characterization 
of Dim1p was carried out in yeast.      
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Figure 8: Cyrstal structures of (a) KsgA (PDB Id- 1QYR) and (b) human Dim1 (PDB Id- 
1ZQ9). 
(a) 
(b) 
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 CHAPTER 2: Expression and purification of soluble Dim1p 
 
Structural and biochemical characterization of any protein requires it to be soluble 
and stable for a reasonable period of time. In order to study the protein using some of the 
most powerful and informative methods such as X-ray crystallography and NMR, high 
protein concentration and long-term stability are required. Preparation of a concentrated 
and stable protein sample is more often a difficult task, as proteins frequently aggregate or 
precipitate at higher concentrations, and are sometimes subject to spontaneous proteolytic 
degradation. The recently published results from high-throughput structural genomics 
programs118 identified poor protein solubility as one of the main bottlenecks. The estimates 
show that on an average only 30% of all the cloned targets could be purified, and the 
number drops to 20% if only eukaryotes are considered. To improve the yield of soluble 
proteins, various strategies are in practice, which include expression of proteins in 
alternative hosts (bacteria, yeast, insect cell, mammalian cell) and optimization of the 
protocols for expression and purification.  
Like many other proteins, expression of soluble yeast 18S rRNA dimethylase, 
Dim1p, has been a challenging task. Dim1p has a poor solubility profile, although its 
orthologs in E. coli and M. jannaschii, KsgA and MjDim1 respectively, were readily 
soluble and have been purified in our laboratory to high concentrations49,70. The sequence 
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homology between the proteins is ~26% which reflects that there are significant 
differences resulting in different physical properties.  
Following the general practice, initial attempts to produce Dim1p has been carried 
out in E. coli as an expression host, because of its simplicity and the availability of wide 
variety of tools that can be used to increase the yield of soluble protein119. The protein 
expression strains, BL-21(DE3) and its derivative, BL21-CodonPlus (DE3)-RIL carrying 
additional tRNAs for eukaryotic codons, were used for expressing Dim1p under general 
conditions. However, almost all of the protein was insoluble due to the formation of 
inclusion bodies in E. coli. Attempts to express soluble Dim1p in Pichia pastoris or as a 
Nus-Dim1p fusion protein in bacteria were also unsuccessful. 
In our next strategy we wanted to express the N and C terminal domains of Dim1p 
separately. The N-terminal domain contains the conserved SAM binding region and our 
assumption was that it should be soluble, based on the fact that other methyltransferases 
with this characteristic domain were soluble and also crystallized. However, when 
expressed in bacteria, the N-terminal domain was also insoluble. We have not attempted to 
express the C-terminal domain alone, as another strategy to express the entire protein had 
been successful. When the entire protein, Dim1p was expressed under mild conditions, 
considerable amount of protein could be purified in soluble form although some amount of 
the protein was still insoluble. The concentration of the soluble protein could be enhanced 
by modifying the buffer conditions.     
 
 
30 
Expression of Nus-Dim1p fusion protein 
NusA protein is highly soluble (> 90%), when expressed in E. coli, and has been 
proven successful in increasing the solubility of many target proteins when attached to 
it120. If the fusion protein was soluble, then NusA protein could be cleaved off and Dim1p 
could be purified. Therefore, Dim1p was attached at the C-terminal end of Nus and 
expressed in E. coli. The fusion protein (MW ~110 kD) also has His tag. The purification 
of proteins was carried out by Ni2+ affinity chromatography and were analysed by SDS-
PAGE. However, the His-tag stain which identifies the His-tagged proteins, clearly shows 
that a large amount of fusion protein was insoluble (Figure 9). The soluble fractions 
showed only a small amount of right sized fusion protein but also had a mixture of proteins 
ranging from 110 kD to 20 kD. This could be due to proteolytic degradation or abrupt 
ending of translation process.    
Expression of Dim1p in Pichia pastoris 
The next strategy was to express Dim1p in Pichia pastoris, a methylotrophic yeast. 
The Pichia pastoris expression system is being used successfully for the production of 
various recombinant heterologous proteins121. This methylotrophic yeast is particularly 
suited to foreign protein expression for a number of reasons, including ease of genetic 
manipulation, high-frequency DNA transformation, cloning by functional 
complementation, high levels of protein expression at the intra- or extracellular level, and 
the ability to perform higher eukaryotic protein modifications, such as glycosylation, 
disulfide bond formation and processing. We were very optimistic about the expression 
Dim1p in another yeast, but to our surprise, the protein could never be expressed.  
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Figure 9: SDS-PAGE analysis of Nus-Dim1p fusion protein. (A) His-tag stain shows the 
His-tagged proteins as fluorescent bands when exposed to UV light. (B) Coomassie blue 
staining. Lane 1 has the insoluble portion of the cell lysate; Lane 2 has the soluble portion 
of cell lysate; Lanes 3-5 have the eluate fractions from the Ni column; Lane 6 has the pre-
stained standards. 
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The plasmid construct encodes Dim1p with N-terminal α-factor secretion signal 
and C-terminal His-tag. The linearized plasmid was transformed into P. pastoris (X-33), 
which were then grown in a large culture and induced with methanol. The α-factor 
secretion signal is responsible for secreting the expressed protein into the medium. 
However, no protein was found after passing the medium over Ni2+ column. The cells were 
also lysed suspecting that the endogenous nuclear localization signal of Dim1p might have 
prevented it from secretion. However, no his-tagged protein could be detected in the cell 
lysate.    
Expression of Dim1p under mild conditions  
Induction of the protein under mild conditions in BL21-CodonPlus (DE3)-RIL cells 
or Rosetta 2 (DE3) cells with pET15b-DIM1 plasmid has finally proved to be successful to 
obtain soluble Dim1p. After growing the culture at 37 ˚C, protein induction was carried out 
at 25 ˚C using one-fifth of the amount of IPTG normally used. Protein purification was 
carried out using affinity chromatography and analysed by SDS-PAGE. Incorporation of 
15% glycerol and 3 mM β-ME in the purification buffers enhanced the amount of soluble 
protein considerably. The his-tag and coomassie staining show that the eluted protein is 
relatively pure and stable during purification procedures (Figure 10). However, the protein 
precipitated out as aggregates during storage for more than couple of weeks at 4˚C. The 
aggregation was also enhanced by freeze-thaw cycles and/or reducing the concentration of 
glycerol and β-ME in the buffer. Attempts to concentrate the protein also led to rapid 
precipitation. 
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Figure 10: Soluble Dim1p. Protein standards have been loaded in lane 1. Two of standards 
(75 kD and 25 kD) also show strong fluorescence with His-tag stain. (A) Dim1p eluate 
fractions stained with coomassie blue; (B) eluate fractions showing fluorescence with His-
tag stain. 
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Discussion 
Purification of soluble and stable protein is a tedious process involving several 
trials. In most cases, strategies are guided by protocols used successfully under similar 
problems or for similar or related proteins. However, because every protein is different, the 
strategies and purification protocols must be worked out for every protein based on its 
intended use. Similarly, the strategies employed for the expression of Dim1p was based on 
successful trials used for other proteins. 
Using large tags, such as the ‘Nus’ to increase the apparent solubility of a target 
protein is a well known method. However, in the case of Nus-Dim1p fusion protein, the 
target protein has dragged considerable amount of soluble carrier into the insoluble 
portion.  Even though some amount of the protein was soluble, it was heterogenous (Figure 
9). His-tag stain suggests that the multiple proteins observed in the eluate belong to the 
fusion protein. Degradation of the fusion protein by a protease could be one of the reason. 
Another reason might be that the translation process is ending abruptly, as the fusion 
protein is very large (~860 aa).  
Failure of the Dim1p expression in Pichia pastoris was also quite surprising. The 
α-factor signal sequence at the N-terminal end of the protein will direct the translated 
protein into the secretory pathway and during the process the signal will be cleaved. 
Dim1p, also has a nuclear localization signal, and the presence of opposing signals on the 
same protein might cause some problem. Another reason could be the post-translational 
modifications occurring on the protein expressed in Pichia, of which O- and N-linked 
glycosylation are most common.  It is possible that Pichia will glycosylate heterologous 
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proteins, even when those proteins are not normally glycosylated by the native host; and 
even when the protein is glycosylated in the native host, Pichia may glycosylate at another 
site122.  
The insolubility of the N-terminal domain of Dim1p, when other 
methyltransferases with the same domain were soluble, was also unexpected. This raises 
the possibility that the aggregation is due to the presence of hydrophobic patches on the 
surface of the Dim1p and the problem worsens as the protein concentration increases.   
So, the expression of soluble Dim1p under mild conditions could be due to the lower 
concentration of protein in the cell and the presence of glycerol and β-ME in the buffers. It 
has also been suggested that slower rates of protein production allow newly transcribed 
recombinant proteins time to fold properly123.  
 
Materials and Methods 
The identification and cloning of DIM1 gene was described by Lafontaine et al.73 
and the plasmid ( pET15b-DIM1 ) was provided to us by Dr. Jean Vandenhaute. It was 
confirmed by sequencing and the construct results in Dim1p with N-terminal His-tag. 
Analysis of the DIM1 gene sequence revealed the use of codons that are rare in E. coli; 
therefore, the protein was expressed in BL21-CodonPlus (DE3)-RIL cells (Stratagene), or 
Rosetta 2 (DE3) cells (Novagen) which contain extra copies of tRNAs for rare codons. 
Expression of Nus-Dim1p fusion protein 
DIM1 was amplified from pET15b-DIM1 as a SmaI-XhoI fragment and subcloned 
into pET44a vector (Novagen) to give pET44a-DIM1 which results in a fusion protein (His 
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tag-Nus tag-His tag-S tag-Dim1p). Primer information is given in appendix. This clone and 
all subsequent clones were confirmed by sequencing at Nucleic Acids Research Facilities, 
Virginia Commonwealth University. 
Protein was expressed in BL21-CodonPlus (DE3)-RIL cells (Stratagene). Cell 
cultures were grown at 37°C to an OD600 of 0.6 in the presence of ampicillin and 
chloramphenicol and induced with 1 mM IPTG. After 4 h at 37°C, cells were harvested by 
centrifugation. Purification was carried out by affinity chromatography using a HiTrap 
Chelating column (Amersham) equilibrated with 0.1 M NiSO4, and buffers with 50 mM 
NaH2PO4, 300 mM NaCl, and imidazole (10 mM in lysis buffer, 20 mM in wash buffer 1, 
50 mM in wash buffer 2 and 300 mM in elution buffer) at pH 8.0. The cell pellets were 
resuspended in lysis buffer and broken by passing through an Avestin EmulsiFlex-C3 
homogenizer two times at 15,000 psi, and centrifuged to remove cell debris. Cleared lysate 
was loaded onto the Ni2+ column, washed and then eluted. 
Expression of N-terminal domain of Dim1p 
The N-terminal region of DIM1 was amplified from pET15b-DIM1 as a NdeI-XhoI 
fragment and subcloned into pET21c vector to give pET21c-DIM1N, which encodes the N-
terminal domain of Dim1p with C-terminal his-tag. Protein expression and purification 
protocol is same as described for Nus-Dim1p protein. 
Expression of soluble Dim1p under mild conditions  
For expression of Dim1p, the plasmid pET15b-DIM1 is transformed into BL21-
CodonPlus (DE3)-RIL cells (Stratagene). Identical results were also obtained with Rosetta 
2 (DE3) cells (Novagen). The transformed cells were grown at 37°C to an OD600 of 1.2 in 
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the presence of ampicillin and chloramphenicol. Then the protein expression is induced 
under mild conditions with 0.2 mM IPTG at 25°C and harvested after 4 h. Purification was 
carried out by affinity chromatography using a Ni2+-NTA Agarose column (Qiagen) and 
buffers with 50 mM NaH2PO4, 300 mM NaCl, 15% glycerol, 3 mM β-mercaptoethanol 
and imidazole (10 mM in lysis buffer, 20 mM in wash buffer 1, 50 mM in wash buffer 2 
and 300 mM in elution buffer) at pH 8.0. The cell pellets were resuspended in lysis buffer 
and broken by passing through an Avestin EmulsiFlex-C3 homogenizer two times at 
15,000 psi, and centrifuged to remove cell debris. Cleared lysate was loaded onto the Ni2+ 
column, washed and then eluted. To increase the stability of the protein, glycerol and 2-
mercaptoethanol were added to the purified protein to final concentrations of 25% and 6 
mM, respectively. The eluate fractions with soluble Dim1p were estimated to be >95% 
pure by SDS-PAGE.  
Expression of Dim1p in Pichia  
DIM1 was amplified from pET15b-DIM1 as a EcoRI-XbaI fragment and subcloned 
into pPICZαA vector to give pPICZαA-DIM1, which encodes the Dim1p with N-terminal 
α-factor secretion signal and C-terminal His-tag. This subcloning procedure was carried 
out in XL1-blue cells using zeocin as the selection marker. The plasmid was linearized in 
the 5´AOX1 region using SacI, and then transformed into Pichia pastoris (X-33) by 
electroporation. The construct gets integrated into AOX1 locus which was confirmed by 
PCR. The transformed Pichia cells were grown at 30˚C to an OD600 of 2-6 in baffled flask. 
The cells were then transferred to a fresh medium containing methanol and the induction is 
maintained for 4 days by the addition of methanol to a final concentration of 0.5% every 
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24 hrs. Samples were collected at regular intervals during the four days and centrifuged to 
separate the medium and cell pellet. Since the protein was intended to be secreted out, the 
medium was loaded onto a HiTrap Chelating column (Amersham) equilibrated with 0.1 M 
NiSO4, washed and eluted with buffers described under Nus-Dim1p fusion protein. The 
cell pellets were resuspended in lysis buffer and broken by passing through an Avestin 
EmulsiFlex-C3 homogenizer three times at 25,000 psi, and centrifuged to remove cell 
debris. Cleared lysate was loaded onto the Ni2+ column, washed and then eluted. The eluate 
fractions in both the cases did not have any Dim1p. 
All the protein samples were analysed by SDS-PAGE using ‘InVision His-tag’ 
stain (Invitrogen) and coomassie blue. 
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CHAPTER 3: Functional Conservation 
 
All ribosomes share the same general architecture, with small and large subunits 
made up of roughly similar rRNA species and a variety of ribosomal proteins. However, 
the fundamental assembly process differs significantly between eukaryotes and eubacteria, 
not only in distribution and mechanism of modifications but also in organization of 
assembly steps. Despite these differences, members of the Dim1/ KsgA methyltransferase 
family and their resultant modification of small-subunit rRNA are found throughout 
evolution and also present in the last common ancestor. The location of the two adjacent 
adenosines near the functional core of the ribosome might be one of the reasons, as critical 
regions of the ribosome have changed very little through out evolution.   
Helix 45 (in E. coli 30S), containing the two dimethylated adenosines in its loop, is 
also one of the most highly conserved sequences in small subunit rRNA47,124. Although the 
Dim1/KsgA family members have diverged to carry out secondary functions, both the 
yeast Dim1p and human mtTFB have been shown to complement for KsgA function in 
bacteria74,97. This indicates that the eukaryotic and organellar enzymes were able to 
recognize the bacterial substrate, which is supported by the fact that the target adenosines 
are located in a highly conserved region of small subunit, favoring such cross reaction. 
Although the actual in vivo substrate for the methyltransferase is not known, substantial 
amount of information is now available from in vitro 30S reconstitution experiments. It has 
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been well established that functional eubacterial ribosomes can be assembled in vitro using 
only the component rRNAs and ribosomal proteins125, although additional factors 
are required in vivo for optimal assembly126. These experiments provided several 
intermediates that were tested for substrate recognition by KsgA. 
16S rRNA alone is not a substrate for KsgA, but a minimal in vitro substrate has 
been found to consist of 16S rRNA plus a subset of ribosomal proteins S4, S6, S8, S11 and 
S15-S18 which are all located in the body and platform of the 30S subunit127. Studies also 
showed that the ribosomal protein S21 is inhibitory for KsgA activity102,127, in an indirect 
way51. It is also known that S21 is assembled in the later stages of 30S biogenesis. 
Therefore, the in vivo substrate for KsgA is an intermediate particle in the 30S biogenetic 
pathway, in which the body and platform have been assembled. KsgA is also able to 
methylate fully formed 30S subunits, although these subunits must be in a translationally 
inactive conformation to support methylation51. Given this, it is striking that KsgA 
orthologs from yeast and human mitochondria can recognize their substrate in bacterial 
ribosomes in vivo. Since a soluble Dim1p is now available (chapter 2), we wanted to test if 
Dim1p can methylate bacterial 30S in vitro, confirming the in vivo data. We have also 
included an ortholog (MjDim1) from an archaeal organism, Methanocaldococcus 
jannaschii, as archaeal rRNA modification seems to be more similar to that found in 
eukaryotic organisms45. Although the overall sequence homology is low across the 
domains, the characteristic motifs responsible for SAM binding (Rossman-like fold) are 
highly conserved (Figure 11). Accordingly, our results indicate that the bacterial, 
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Figure 11. Structure-based sequence alignment of Dim1p from S. cerevisiae (ScDim1, 
P41819), Homo sapiens (HsDim1, Q9UNQ2), bacteria (E. coli- KsgA, P06992), and 
archaea (M. jannaschii- MjDim1, NP_248023). Structures used for alignment were those 
of KsgA (PDB ID 1QYR) and HsDim1 (PDB ID 1ZQ9). The alignment was generated 
using the TCoffee Web server128. Identical residues are denoted with an asterisk, strongly 
conserved residues with a colon, and weakly conserved residues are marked with a period. 
The glutamate highlighted in grey (85th residue in yeast Dim1p) is mutated to alanine to 
obtain catalytically inactive enzyme, resulting in non-dimethylated 40S subunits. (A) 
indicates VD residues in the linker region at which domains were swapped for the 
construction of chimeras. (B) indicates the insert in C-terminal domain of Dim1 which is 
absent in KsgA but partially present in MjDim1. Dashed arrows indicate motifs common 
to SAM-dependent methyltransferases.  
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eukaryotic, and archaeal enzymes can recognize a common bacterial substrate, despite 
differences in their respective small subunit maturation processes. 
  
In vivo analysis 
Dim1p has been shown to complement for KsgA function in ksgA − E. coli cells73, 
demonstrating functional equivalence of the two proteins. We asked whether MjDim1 
could also complement the function of KsgA. In vivo activities of both Dim1p and 
MjDim1 were assessed using a modified minimal inhibitory concentration (MIC) assay, 
which takes advantage of the fact that loss of KsgA function renders bacteria resistant to 
the antibiotic kasugamycin (ksg)100,101. Plasmids containing the two proteins were 
transformed separately into a ksgR strain of E. coli, which lacks endogenous KsgA activity. 
This strain was constructed from BL-21 (DE3) cells; this allows leaky expression from the 
pET15 T7 promoter. Growth on ksg was compared to cells transformed with pET15b-
KsgA plasmid (positive control) and cells transformed with empty vector (negative 
control). Unlike in a traditional MIC, untransformed cells are naturally resistant to the 
antibiotic and become sensitive when transformed with a functional dimethyltransferase. 
Therefore, cells transformed with KsgA have a low MIC of 400 μg/mL ksg, while cells 
transformed with an empty vector have a high MIC, greater than 3000 μg/mL ksg. As 
shown in Figure 12, MjDim1 is fully functional in this in vivo system, with an MIC of 400 
μg/mL. Dim1p, on the other hand, shows partial activity on bacterial ribosomes in vivo, 
with an MIC of 1200 μg/mL. While Dim1p does not restore full sensitivity to the 
antibiotic, it does show increased sensitivity, indicating that the enzyme is able to  
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                              Figure 12: In vivo activity of Dim1p orthologs 
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recognize the small subunit as a substrate. Lack of full complementation may correlate 
with slower and/or incomplete methylation of 30S as compared to the other two enzymes73 
(see nucleotide analysis). 
In vitro analysis 
We next tested how efficiently Dim1p and MjDim1 were able to methylate E. coli 
30S in an in vitro assay. Unmethylated 30S subunits were prepared from the ksgR strain 
described above. Incorporation of 3H-methyl group from labeled SAM by each enzyme 
was followed at discrete time points over an interval of two hours. Control experiments 
were performed with 30S subunits purified from wild-type E. coli cells, which are 
methylated by endogenous KsgA and thus do not serve as substrates. Initial experiments 
were performed with 10 pmol of 30S substrate and 1 pmol of enzyme. This amount of 
protein did not allow for completion of the reaction within two hours, so experiments were 
also performed using 10 pmol each of 30S and enzyme. 
Figures 13a, 13b, and 13c show the time course of methylation for Dim1p, KsgA, 
and MjDim1 respectively. Methylation of E. coli 30S by Dim1p and MjDim1 closely 
followed the KsgA time course, both in rate of incorporation and final level of 
methylation. In reactions with 1 pmol of enzyme, MjDim1 showed a slightly higher rate of 
3H incorporation than KsgA and ScDim1 at later time points. With stoichiometric amounts 
of protein relative to 30S, the time course of methylation was essentially indistinguishable 
between the three proteins, thus confirming the ability of the enzymes from eukaryotes and 
archaea to recognize bacterial 30S subunits as substrates. 
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Figure 13: In vitro methylation of 30S. Time-course assays for (a) Dim1p, (b) KsgA, and 
(c) MjDim1. Blue lines indicate assays containing 10 pmol ksgR 30S, 10 pmol enzyme; 
orange lines indicate assays containing 10 pmol ksgR 30S, 1 pmol enzyme; green lines 
indicate control assays containing 10 pmol wt 30S subunits, 10 pmol enzyme. Assays were 
performed in triplicate; error bars represent standard deviation. 
 
(a) 
(b) 
(c) 
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We then estimated the amount of methyl groups transferred at the two-hour time 
point by each enzyme, with both 1 pmol and 10 pmol amounts of enzyme, by constructing 
a standard curve of cpm versus concentration of 3H-methyl-SAM. With 10 pmol of 30S per 
reaction, and four methylation sites per 30S molecule, we would expect to see transfer of 
40 pmol methyl groups if the reactions have gone to completion. As shown in Figure 14, 
our calculations lead to slight overestimation of methyl group transfer, probably due to 
error in 3H counting. However, the reactions performed with 10 pmol enzyme appear to be 
more or less complete after 2 hours. Reactions performed with only 1 pmol enzyme are 
approximately halfway completed after 2 hours. 
Nucleoside analysis 
In vitro assays of the three proteins, performed as described above for the time 
course, were incubated for 2 hours and analyzed to determine relative amounts of m6A and 
m26A (Figure 15; Table 1). 16S rRNA isolated from 30S subunits methylated by 10 pmol 
of either KsgA or MjDim1 contained no detectable labeled m6A; radioactive incorporation 
was seen only in the dimethyladenosine peak. This agrees with the in vitro data suggesting 
that these reactions have gone to completion (Figure 14). Dim1p, on the other hand, 
produced a mixture of m6A and m26A; approximately 28% of the incorporated radiolabel 
was found on monomethylated adenosine. This indicates that at most 80% of the potential 
sites were methylated after two hours. 
Partially methylated 30S from reactions using 1 pmol of enzyme showed 
radioactive peaks at both m6A and m26A. Surprisingly, although the total level of 
methylation was similar for all three enzymes (Figure 14), rRNA methylated by the 
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Figure 14: Quantitation of methyl groups transferred after two hours. Blue bars represent 
assays performed with 10 pmol enzyme; yellow bars represent assays using 1 pmol 
enzyme. Assays were performed in triplicate; error bars represent standard deviation. 
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Table 1: Quantitation of methylated adenosine species. 
 
  total CH3 
(pmol)a 
m6A : m26A 
ratio 
m6A 
(pmol) 
m26A 
(pmol)b 
 
Dim1p 
 
1 pmol 
10 pmol 
 
 
20.1 ± 0.7 
47.4 ± 2.7 
 
1.4 : 1 
0.8 : 1 
 
8.3 
13.5 
 
5.9 
16.9 
KsgA 1 pmol 
10 pmol 
 
18.1 ± 1.7 
37.4 ± 10.1 
0.8 : 1 
- 
5.2 
NDc 
6.5 
37.4 
MjDim1 1 pmol 
10 pmol 
 
24.1 ± 3.6 
48.1 ± 8.8 
0.02 : 1 
- 
0.2 
ND 
11.9 
48.1 
 
aData from Figure 14. 
b1 pmol m26A corresponds to 2 pmol methyl groups. 
cND - none detected. 
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Figure 15: Nucleoside analysis by HPLC. (a) UV chromatogram showing the retention 
times of 4 major nucleosides present in 16S rRNA along with the exogenously added 
nonradioactive reference nucleosides, m6A and m26A. (b) Chromatogram showing the 
radio-labeled m6A and m26A, obtained after the in vitro methylation of 10 pmol ksgR 30S 
using 1 pmol Dim1p. 
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different enzymes showed different ratios of m6A to m26A. Dim1p produced approximately 
1.4 times as much m6A as m26A. MjDim1, conversely, produced almost no m6A; only 
about 1% of the incorporated methyl groups were found on m6A. KsgA fell somewhere 
between the other two, producing both m6A and m26A, with only 0.8 times as much m6A as 
m26A. These results could be a result of assaying enzymes from different species on the 
bacterial substrate, or they could reflect a difference in reaction mechanism. 
 
 Discussion 
The Dim1/KsgA enzymes transfer a total of four methyl groups from four SAM 
molecules to two adenosines. The exact mechanism of transfer has not yet been 
established; questions remain as to order of addition, if any, and the number of binding 
events required for the four methylations. The above data begin to address the question of 
the multiple methyl group transfers. Partially methylated 30S were produced in reactions 
containing 10 pmol 30S subunits and 1 pmol enzyme. Therefore, m6A produced in excess 
of 2 pmol (corresponding to two adenosines available for methylation per subunit) will 
only be seen if the enzyme releases the substrate after monomethylation and rebinds to a 
new substrate. With 20.1 pmol of methyl groups incorporated by 1 pmol Dim1p, the 1.4:1 
m6A:m26A ratio represents approximately 8.3 pmol labeled m6A and 5.9 pmol labeled 
m26A (1 pmol m26A represents 2 pmol incorporated methyl groups). Therefore, under our 
assay conditions, Dim1p clearly releases the m6A intermediate, which is subsequently 
converted to the m26A product after an additional binding event. 
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In contrast, there is no indication that MjDim1 produces m6A as anything but a 
transient intermediate. Of the 24.1 pmol methyl groups transferred, only 0.3 pmol were 
found on m6A. These results suggest that the archaeal enzyme preferentially forms 
dimethyladenosine, without release of the monomethyl intermediate. While release of a 
monomethyl intermediate and subsequent rebinding and addition of the second methyl 
cannot be ruled out, such a model requires that MjDim1 prefers the monomethylated 
substrate to the unmethylated substrate to a large degree. 
In terms of m6A vs. m26A production, KsgA falls somewhere in between Dim1 and 
MjDim1. Unlike Dim1p, KsgA produces less m6A than m26A; however, of the 18.1 pmol 
of methyl groups transferred, 5.2 pmol are found on m6A, which is still indicative of a 
released intermediate. Although it is possible that these differences are a result of 
suboptimal assay conditions, these results also allow the possibility of distinct mechanisms 
for the three enzymes, thus demonstrating a need for future analysis to dissect the exact 
scheme of methyl transfer. 
Substrate recognition by the Dim1/KsgA methyltransferases is complex. KsgA is 
able to methylate 30S subunits, but it can also methylate a pre-ribosomal particle 
containing 16S and a partial complement of ribosomal proteins127. Dim1 is essential for 
early processing of the pre-rRNA, but does not methylate 20S until very late in the 40S 
maturation process74. Despite evolutionary divergence of ribosomal assembly and 
processing pathways, eukaryotic and archaeal KsgA orthologs are able to methylate E. coli 
30S both in vivo and in vitro. This requires the conservation of similar structural cues in 
small ribosomal subunits across evolution. Also complex is the mechanism of the 
52 
modification performed by these enzymes. A total of four methyl groups are transferred, 
from four SAM molecules, to two separate adenosines. It is clear from the crystal structure 
of KsgA70 that only one SAM molecule is bound at a time, and that the adenosines enter 
the active site separately. It has not been determined in what order, if any, the methyl 
groups are transferred, or if all four of the transfers take place within a single or multiple 
binding events. This work demonstrates clear differences in the reaction intermediate 
profiles produced in vitro by Dim1/KsgA enzymes from bacteria, archaea, and yeast, 
despite the fact that the three enzymes methylate bacterial 30S to a similar extent and at 
similar rates in the assay used. However, we cannot exclude the possibility that the 
differences in the respective rates of m6A and m26A production seen here are a result of 
suboptimal substrate or assay conditions rather than a reflection of true differences in 
mechanism. For example, the yeast and archaeal enzymes may show different activity if 
assayed on their respective small ribosomal subunits rather than on bacterial 30S. These 
results demonstrate the remarkable cross-recognition of a complex substrate by 
evolutionarily distant members of an enzyme family and emphasize the need to further 
investigate the multistep reaction mechanism. 
 
Materials and Methods: 
KsgA from E. coli and MjDim1 from M. jannaschii were previously cloned in our 
laboratory into pET15b vector49,129 which results in respective proteins with N-terminal 
His tag. 
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Protein expression and purification 
pET15b-KsgA and pET15b-MjDim1 plasmids were transformed into BL-21 (DE3) 
cells for overexpression. Cell cultures were grown to an OD600 of 0.6 in the presence of 
ampicillin and induced with 1 mM IPTG. After 4 h at 37°C, cells were harvested by 
centrifugation. Purification was carried out by affinity chromatography using a HiTrap 
Chelating column (Amersham) equilibrated with 0.1 M NiSO4, and buffers with 50 mM 
NaH2PO4, 300 mM NaCl, and imidazole (10 mM in lysis buffer, 20 mM in wash buffer 1, 
50 mM in wash buffer 2 and 300 mM in elution buffer) at pH 8.0. The cell pellets were 
resuspended in lysis buffer and broken by passing through an Avestin EmulsiFlex-C3 
homogenizer two times at 15,000 psi, and centrifuged to remove cell debris. Cleared lysate 
was loaded onto the Ni2+ column, washed and then eluted. 
Dim1p was expressed and purified as described in Chapter 2. Proteins were 
estimated to be >95% pure by SDS-PAGE analysis. Protein concentration was measured 
using the Bio-Rad Protein Assay. 
30S purification 
An E. coli strain lacking functional KsgA was constructed by growing BL-21 
(DE3) cells on kasugamycin (ksg) to select for loss of the dimethylations. 30S ribosomes 
from this ksgR strain were used in an in vitro assay to confirm that the adenosines were 
able to be methylated, and therefore that the resistance to ksg was due to lack of KsgA 
activity. 30S subunits from both ksgR strain and the wild-type strain were prepared as 
described by Blaha et al.130, except that cells were broken as described above. Purified 
subunits were dialyzed into reaction buffer (40 mM Tris at pH 7.4; 40 mM NH4Cl; 4 mM 
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MgOAc; 6 mM 2-mercaptoethanol) and stored at –80°C in single-use aliquots. 30S 
concentration was estimated by measuring the absorbance at 260 nm and using a 
relationship of 67 pmol 30S per 1 unit of optical density. 
In vivo assay 
ksgR cells were transformed with the pET15b constructs of DIM1, KsgA, and 
MjDim1 and selected on LB plates containing ampicillin. Transformed colonies were 
inoculated into liquid media and grown overnight. These cultures were diluted 1:25 in 
fresh LB containing 50 μg/mL ampicillin and grown to OD600 of 0.7-0.8. The cultures were 
again diluted 1:100 with fresh LB and 3 μL of the dilution was plated onto LB/ ampicillin 
containing increasing amounts of kasugamycin, from 0 to 3000 μg/mL. Plates were 
incubated at 37°C overnight and visually inspected for colony formation. 
In vitro assay 
The in vitro assay was adapted from Poldermans et al102. Time-course reactions 
were performed in 500 μL volumes containing 40 mM Tris (pH 7.4), 40 mM NH4Cl, 4 
mM MgOAc, 6 mM 2-mercaptoethanol, 1 mM SAM with 0.02 mM 3H-methyl-SAM (780 
cpm/pmol; MP Biomedicals), 100 pmol 30S subunits, and 10 or 100 pmol enzyme; volume 
and components were sufficient for 10 reactions. Buffer and reagents were prewarmed to 
37°C and added into prewarmed tubes to minimize any lag in the reaction start. At each of 
eight designated time points 50 μL was removed and added to a prechilled tube containing 
10 μL of 100 mM unlabeled SAM (Sigma-Aldrich) to quench the reaction; the remaining 
100 μL was stored at −20°C and used for HPLC analysis (see below). The quenched 
reactions were deposited onto DE81 filter paper (Whatman), washed twice with ice-cold 
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5% TCA, and rinsed briefly with ethanol. Filters were air-dried for one hour, placed into 
scintillation fluid, and counted. 
HPLC analysis 
Labeled 16S rRNA was extracted from 30S subunits with phenol/ chloroform/ 
isoamyl alcohol. 16S was digested and dephosphorylated as described by Gehrke and 
Kuo131, and subjected to nucleoside analysis by reversed-phase HPLC. Nuclease P1 was 
obtained from USBiological, shrimp alkaline phosphatase was from MBI Fermentas. 
HPLC analysis was performed using a Polaris C-18 column (Varian). The HPLC system 
used consisted of a Waters 600 Controller, a Waters 2487 Dual λ Absorbance Detector, 
and Waters Empower software. Radioactivity was monitored with a Packard 150TR Flow 
Scintillation Analyzer. Buffer A was 20 mM NaH2PO4 (pH 5.1). Buffer B was 20 mM 
NaH2PO4 (pH 5.1):acetonitrile 70:30. Separation was performed at room temperature using 
a linear gradient from 100%A-100%B over 20 min, at a flow rate of 1.0 mL/min. 
Nucleoside standards used were N6-methyladenosine (Sigma-Aldrich) and N6 N6-
dimethyladenosine, synthesized as described by Rife et al.132. Peak integration was 
calculated by the Empower software and used to determine ratios of m6A:m26A. 
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CHAPTER 4: Structural characterization of Dim1p 
 
The members of Dim1/KsgA family, interestingly, have evolved to carryout other 
functions in the cell, apart from the dimethylation. This is clearly evident in eukaryotic 
Dim1 which has an indispensable role in pre-rRNA processing and hence survival of the 
organism. The enzymatic function of Dim1p in dimethylation can be uncoupled from its 
involvement in pre-rRNA processing indicating that dimethylation is not required for its 
second function50. Recently it has been shown that KsgA is also involved in pre-rRNA 
processing in E.coli. Knockout of KsgA leads to a processing defect resulting in the 
accumulation of immature small subunit rRNA (Connolly K, Rife JP, Culver GM, 
unpublished results). Unlike eukaryotes, this processing defect is not detrimental, as 
functional 30S subunits could still be formed. The Dim1 ortholog in eukaryotic 
mitochondria, mtTFB, serves as a mitochondrial transcription factor as well as being the 
dimethyltransferase for mitochondrial 12S rRNA97,109. Similar to Dim1, it has been found 
that the methylation activity of human-mtTFB can be separated from its transcription 
activity110. To perform these secondary functions, the Dim1 orthologs have undergone 
structural changes which is supported by the fact that the sequence homology (~25%) 
across the kingdoms is relatively low. In order to comprehend the precise role of Dim1 
orthologs in their secondary functions, it is important to explore their structural features in 
detail.  
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Despite the low sequence homology, it has been now demonstrated that Dim1p and 
MjDim1 can methylate bacterial 30S subunits in vivo and in vitro49,73 (see Chapter 3). This 
indicates that the bacterial, eukaryotic and archaeal enzymes can recognize a common 
bacterial substrate, despite differences in their respective small subunit maturation 
processes. However, it is not yet known if the bacterial and archaeal enzymes can 
complement the functions of Dim1p. The recent report that KsgA is also involved in pre-
rRNA processing in E.coli, appears to support this assumption. Archaeal ribosome 
biogenesis appears to be more similar to that found in eukaryotes based on the presence of 
putative homologs to nuclear and nucleolar structural genes from eukaryotes and snoRNA 
guided nucleotide modifications133,134. Considering the above facts, the primary question 
we wanted to ask is whether KsgA and MjDim1 can recognize a substrate in eukaryotic 
ribosome biogenesis and complement the multiple functions of Dim1p.  
Sequence alignment of eukaryotic Dim1p with bacterial and archaeal orthologs 
revealed a reasonable similarity in the N-terminal domain which includes the S-
adenosylmethionine (SAM) binding domain (Figure 11). However, the most outstanding 
feature in the alignment is the presence of an insert in the C-terminal domain of eukaryotic 
and in some archaeal Dim1 which is totally absent in the bacterial protein (KsgA). The 
length of the insert in archaea (MjDim1) is slightly less than that in eukaryotes (Figure 11). 
Structural alignment using the currently available crystal structures of human Dim1 
(HsDim1, PDB Id: 1ZQ9) and KsgA (PDB Id: 1QYR) shows that the insert in the C-
terminal domain of Dim1p forms an extra helix along with a section of random coil and 
another slightly longer helix than that present in KsgA (Figure 16a and 16b). It is possible 
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Figure 16: (a) Superposition of KsgA (blue) with HsDim1 (green). The insert in the C-
terminal domain of HsDim1 is shown in red. (b) Side view of the C-terminal domain and 
the insert. 
(a) 
(b) 
Flexible 
linker 
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that this extra helix in the C-terminal domain of Dim1p makes an important interaction 
with RNA or another protein in the 90S pre-ribosomal particle which is essential for 
cleavage at sites A1 and A2. One possible candidate for such an interaction is Dim2p (also 
known as RRP20 and PNO1), which also was found to be essential for the A1, A2 
cleavages and for the dimethylation carried out by Dim1p76,77. It was speculated that 
Dim2p might associate with Dim1p in the above functions.   
Another unresolved question is about the preferred substrate of Dim1p. Binding of 
Dim1p to 90S pre-ribosomes occurs very early in the biogenetic pathway and Dim1p 
remains bound to pre-40S particles during nuclear export and cytoplasmic maturation until 
the dimethylation is complete21,22. Dimethylation is thought to be the penultimate step in 
maturation, occurring just before the final cleavage (Cleavage D) which converts 20S 
rRNA to 18S. In our earlier work (chapter 3), we have shown that Dim1p can methylate 
the 30S subunits of E.coli in vitro49, which indicates that Dim1p recognizes the fully 
assembled 30S subunits, but its activity remains untested against non-dimethylated but 
otherwise mature 40S subunits. We have generated non-dimethylated 40S subunits and 
tested Dim1p, MjDim1 and KsgA for their ability to utilize these particles as substrates for 
methylation. 
  
Complementation Assay 
Because the yeast DIM1 gene is essential, we used the plasmid shuffle technique, a 
general method for introducing mutations into cloned essential genes135, to test the ability 
of DIM1 orthologs for complementing its function in vivo (Figure 17). A haploid yeast 
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                     Figure 17: Plasmid shuffling technique. Continued in next page 
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Figure 17: Plasmid shuffling technique. One of the DIM1 chromosomal copy in the diploid 
strain was replaced with kanMX4 module by homologous recombination. The 
heterozygous diploid was then transformed with a plasmid carrying a wild type DIM1 gene 
and also a URA3 marker (pESC-URA-DIM1). Sporulation yields a haploid yeast strain with 
chromosomal DIM1 knock-out. This strain is used to test a ‘target’ gene cloned into a 
second plasmid (pESC-LEU) after curing the first plasmid, pESC-URA-DIM1, in presence 
of 5-FOA. 
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 strain was constructed that carried a deletion of the chromosomal copy of DIM1. Viability 
of this strain, Y26hα-URA-DIM1, was maintained with a copy of the wild-type gene on a 
plasmid that also carries the URA3 marker (pESC-URA-DIM1). To introduce the orthologs 
of DIM1, this strain was transformed separately with pESC-LEU vectors containing KsgA 
and MjDim1, both with and without an exogenous NLS, to ensure that the expressed 
proteins would be targeted to the nucleus. As a positive control, the strain was transformed 
with the pESC-LEU vector carrying the wild-type DIM1 gene (pESC-LEU-DIM1) and the 
strain transformed with the vector alone (pESC-LEU) was used as a negative control. To 
test complementation of the dim1-∆ allele by KsgA or MjDim1, we plated the cells on 
medium containing 5-fluoroorotic acid (5-FOA). Because 5-FOA is toxic to yeast cells 
expressing URA3, this treatment allows selection of cells that have lost the plasmid 
carrying URA3 and at the same time, the wild-type copy of the DIM1 gene.  Plates were 
incubated for 3 days at 30˚C and except for the positive control (Y2P-DIM1) none of the 
constructs of KsgA or MjDim1 were able to rescue the lethal phenotype of the dim1 
knockout (Figure 19a). In order to ascertain that the exogenous NLS is not interfering with 
the activity, another construct in which NLS is fused to the N-terminal end of Dim1p was 
tested as a control and found that it is innocuous (result not shown).  
Role of C-terminal insert in Dim1p function 
Next, we wanted to ascertain the role of the extra insert in the C-terminal domain of 
Dim1p in yeast and other eukaryotes by taking advantage of the two domain architecture of 
the KsgA/Dim1 family. In KsgA, the N- and C-terminal domains can move independently 
of each other to some degree70, allowing construction of chimeric proteins which contain 
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domains from two proteins. If the insert is critical to Dim1’s function as a participant in the 
A1/A2 cleavage steps, then chimeras that include the C-terminal domain of Dim1 could be 
suitable Dim1 substitutes.  
The linker between the two domains in Dim1p has two residues, valine and 
aspartate which are also found in the linker region of KsgA but with a lysine in between 
them. Sequence alignment shows that the corresponding position in MjDim1 has 
isoleucine and glutamate (indicated in Figure 11). These two residues were selected as a 
center for domain swapping. To construct chimeric proteins, the N and C terminal domains 
of DIM1, KsgA and MjDim1 were amplified separately and ligated in all six possible 
combinations. Chimeras were named to indicate the origin of each domain (Table 2 and 
Figure 18). All of the six chimeric genes were cloned into pET15b and the proteins were 
overexpressed in E. coli and shown to be soluble, although to varying degrees with DK (N-
terminal domain of Dim1p and C-terminal domain of KsgA) being poorly soluble (data not 
shown). The chimeras were also assessed in an in vivo assay in bacteria, and shown to 
complement for KsgA function, again to varying degrees (Table 3). These results show 
that the chimeric proteins are able to assemble and fold in a productive manner. 
The chimeric genes were then subcloned into pESC-LEU and transformed into 
Y26hα-URA-DIM1; the transformants were plated on 5-FOA. Interestingly, only Y2P-DM 
survived, showing that the only chimera able to complement the function of Dim1p is a 
construct with the N-terminal domain of Dim1p and C-terminal domain of MjDim1 
(Figure 19b).  
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                                          Table 2: Chimera protein construction 
Parent Domains Chimera protein 
N terminal – KsgA 
C terminal – Dim1 
KD 
N terminal – Dim1 
C terminal – KsgA 
DK 
N terminal – MjDim1 
C terminal – Dim1 
MD 
N terminal – Dim1 
C terminal – MjDim1 
DM 
N terminal – MjDim1 
C terminal – KsgA 
MK 
N terminal – KsgA 
C terminal – MjDim1 
KM 
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Swap domains
KsgA Dim1 MjDim1
KD1 DK2 MK5DM4MD3 KM6  
Figure 18: Chimera protein construction. The N and C-terminal domains of KsgA, Dim1p 
and MjDim1 were swapped to obtain six chimera proteins 
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Table 3: In vivo activity assay in E.coli 
Plasmid MIC (μg/mL ksg)† 
pET15b >3000 
pET15b-KsgA 400 
pET15b-DIM1 1200 
pET15b-MjDim1 400 
pET15b-KD 1200 
pET15b-DK 2000* 
pET15b-MD 400 
pET15b-DM 2000* 
pET15b-MK 400 
pET15b-KM 800 
 
† Concentrations of Kasugamycin (Ksg) in μg/mL used in the assay are 0, 200, 400, 600, 
800, 1000, 1200, 1500, 2000, 2500, 3000. 
* Very small colonies were observed 
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Figure 19: Complementation assay on 5-FOA plates at 30˚C for 3 days (a) of different 
constructs of KsgA, MjDim1, (b) chimeras and (c) dim1-E85A. Y2P-DIM1 (positive 
control), Y2P-DM, Y2P-E85A survived on 5-FOA, losing the first plasmid, pESC-URA-
DIM1 and hence these clones with only the second plasmid were relabeled Y-DIM1, Y-
DM, Y-E85A respectively. Y2P-LEU with no insert in the second plasmid is the negative 
control. 
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Table 4: Yeast Strains used in the study 
Genotype -  MATα his3Δ1 leu2Δ0 ura3Δ0 dim1Δ0::KanMX4 
Strain Plasmid/s 
Y26hα-URA-DIM1 pESC-URA-DIM1 † 
Y2P-DIM1 pESC-URA-DIM1, pESC-LEU-DIM1 
Y2P-DIM1-2 pESC-URA-DIM1, pESC-LEU-DIM1-2* 
Y2P-KsgA pESC-URA-DIM1, pESC-LEU-KsgA* 
Y2P-KsgA-2 pESC-URA-DIM1, pESC-LEU-KsgA-2 † 
Y2P-KsgA-3 pESC-URA-DIM1, pESC-LEU-KsgA-3 
Y2P-MjDim1 pESC-URA-DIM1, pESC-LEU-MjDim1* 
Y2P-MjDim1-2 pESC-URA-DIM1, pESC-LEU-MjDim1-2            
Y2P-LEU pESC-URA-DIM1, pESC-LEU 
Y2P-KD pESC-URA-DIM1, pESC-LEU-KD* 
Y2P-DK pESC-URA-DIM1, pESC-LEU-DK 
Y2P-MD pESC-URA-DIM1, pESC-LEU-MD* 
Y2P-DM pESC-URA-DIM1, pESC-LEU-DM 
Y2P-MK pESC-URA-DIM1, pESC-LEU-MK* 
Y2P-KM pESC-URA-DIM1, pESC-LEU-KM* 
Y2P-E85A pESC-URA-DIM1, pESC-LEU-dim1-E85A 
5-FOA resistant clones 
Y-DIM1 pESC-LEU-DIM1 
Y-DIM1-2 pESC-LEU-DIM1-2* 
Y-DM pESC-LEU-DM 
Y-E85A pESC-LEU-dim1-E85A 
 
* Protein from pESC-LEU plasmid has exogenous NLS at the N-terminal end  
† Dim1p from pESC-URA-DIM1 has N-terminal myc epitope; KsgA from pESC-LEU-
KsgA-2 has N-terminal FLAG epitope. All the remaining protein constructs have a C-
terminal FLAG epitope 
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Immunofluorescence 
We next wanted to ascertain that KsgA, MjDim1 and the chimeras were able to 
enter the nucleus, where A1 and A2 processing occurs. All of the proteins have a FLAG 
epitope at the C-terminal end, and can thus be tracked by immunofluorescence microscopy 
(Figures 20-23 and Appendix). Results show that all of the proteins were expressed in 
good amounts and could be observed everywhere in the cell, including the nucleus. In the 
case of DM, dim1-E85A, MjDim1 and MD some cells showed a greater nuclear 
concentration of the protein, while the remaining cells had no distinction between the 
nuclear and cellular concentration of the protein (Figures 20-23). In the case of KsgA, KD, 
DK, MK, and KM the protein was mostly ubiquitous in the cells (Appendix-Figures 28-
32). However, none of the proteins were excluded from the nucleus, which confirms that 
the failure of complementation is not because of failure of entry into the nucleus. 
In vitro activity 
The N-terminal domain of KsgA/Dim1 family shares the Rossman-like fold 
characteristic of SAM-utilizing methyltransferases, known as the AdoMet dependent 
MTase fold, and Motif II of this fold has a highly conserved acidic residue (E85 in yeast 
Dim1p) which forms hydrogen bonds with hydroxyl groups on the ribose moiety of SAM68 
(Figure 24). Mutation of this residue in bacteria leads to a catalytically dead enzyme (data 
not shown). In order to produce non-dimethylated 40S subunits, the E85A mutation was 
introduced into DIM1 and the resultant mutant plasmid, pESC-LEU-dim1-E85A was 
transformed into Y26hα-URA-DIM1 to give Y2P-E85A. As expected, Y2P-E85A 
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Figure 20: Subcellular localization of MjDim1. (a) the nuclei were stained blue with DAPI; 
(b) the protein is stained red with anti-FLAG antibody;  (c) shows the overlay of the 
nucleus and protein; (d) shows the DIC image. 
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Figure 21: Subcellular localization of the chimera protein, MD. (a) the nuclei were stained 
blue with DAPI; (b) the protein is stained red with anti-FLAG antibody;  (c) shows the 
overlay of the nucleus and protein; (d) shows the DIC image. 
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Figure 22: Subcellular localization of the chimera protein, DM. (a) the nuclei were stained 
blue with DAPI; (b) the protein is stained red with anti-FLAG antibody;  (c) shows the 
overlay of the nucleus and protein; (d) shows the DIC image. 
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Figure 23: Subcellular localization of the catalytically inactive protein, dim1-E85A. (a) the 
nuclei were stained blue with DAPI; (b) the protein is stained red with anti-FLAG 
antibody;  (c) shows the overlay of the nucleus and protein; (d) shows the DIC image. 
 (See Figures 28-32 in appendix for the remaining strains) 
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survived in the presence of 5-FOA; the resultant clone was relabeled as Y-E85A (Figure 
19c).  
  In order to determine if the absence of dimethyl groups has an effect on the growth 
phenotype, Y-E85A was spotted on minimal media plates along with Y-DIM1 (with wild 
type Dim1p) as a control and incubated at 25, 30, 37˚C for 3 days and at 18˚C for 4 days. 
Both the strains showed identical growth at all the temperatures indicating the loss of 
methyl groups is not detrimental to cell growth (Figure 25). Non-dimethylated and wild 
type 40S subunits were then purified from Y-E85A and Y-21026 respectively. The 
methylation status of the subunits was confirmed by primer extension analysis carried out 
on 18S rRNA isolated from the subunits with an oligonucleotide complementary to the 
very 3´ end of the mature 18S rRNA. The primer extension was blocked in wild type 18S 
rRNA from strain Y-21026 due to the presence of m26A, but not in the non-dimethylated 
18S rRNA from strain Y-E85A (Figure 26).  
             Dim1, KsgA, and MjDim1 were tested in vitro for their efficiency to methylate the 
non-dimethylated 40S using labeled (3H-methyl) SAM. However, none of the proteins was 
able to do so, but they could all methylate non-dimethylated bacterial 30S, which was used 
as a control to confirm that the enzymes were active49. Dim2p was shown to be required 
for the dimethylation of 40S by Dim1p in vivo76. In a separate experiment Dim2p was 
added to the in vitro reaction along with Dim1p. We also carried out the assay in presence 
of cell lysate, speculating that some other factors might be necessary for the reaction. 
However, even in the presence of Dim2p or cell lysate the 40S subunits could not be 
methylated by Dim1p. We confirmed that the catalytically inactive dim1-E85A protein did 
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Figure 24: SAM binding to Dim1p. The –COOH groups of the E85 residue (only the side 
chain is shown) form hydrogen bonds with the hydroxyls of the ribose sugar of SAM. 
Mutation of E85 to alanine prevents the SAM binding and leads to catalytically dead 
enzyme.  
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Figure 25: Growth phenotypes of Y-DIM1 (with wild type Dim1p) and Y-E85A (with 
catalytically inactive dim1-E85A protein). Both the strains showed identical growth rates. 
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Figure 26: Primer extension analysis on 18S extracted from wild type 40S (wt) and from 
non-dimethylated 40S (N). Arrow indicates the band representing the primer extension 
stop resulting from the presence of the dimethylated adenosines in wild type 40S. In case 
of non-dimethylated 40S, the polymerase reads through the modification site indicating the 
absence of dimethylation. A partial DNA sequence (A,T) of 18S from the non-
dimethylated 40S is also shown. P refers to the N-labeled primer used in the experiment. 
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Figure 27: Western blotting. To confirm the absence of catalytically inactive dim1-E85A 
protein in the purified non-dimethylated 40S subunits. Lane 1 has the protein standards; 
lane 2 has wild-type 40S sample; lane 3 has non-dimethylated 40S sample; lane 4 has 
BAP-Flag (Sigma) fusion protein as a positive control. The dim1-E85A protein with a C-
terminal Flag epitope (~38 kD) was not found in the 40S samples as indicated by (a) 
coomassie stain and (b) western blot using mouse Anti-Flag antibody and goat anti-mouse 
ab conjugated with HRP.  
 
 
 
 
(a) (b) 
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not co-purify with the 40S subunits (by western blot), which could have potentially 
blocked the access of catalytically active Dim1p in our in vitro assays (Figure 27). 
 
Discussion    
Our results show that neither KsgA nor MjDim1 is able to complement the lethal 
Dim1p knockout in yeast. Since the dimethylation function of these enzymes is 
dispensable, this indicates that KsgA and MjDim1 failed to carry out the role of Dim1p in 
the A1 and A2 processing events. Recent studies show that KsgA is also involved in pre-
16S rRNA processing, although the processing defects in the KsgA knockout strain are not 
lethal. Ribosome biogenesis in archaea is speculated to be relatively similar to that of 
eukaryotes, based on the presence of guide snoRNAs and putative homologs to nuclear and 
nucleolar structural genes134. However, failure of functional complementation by MjDim1 
suggests that the eukaryotic enzyme has further evolved to carry out the processing 
function. We hypothesized that the emergence of this function may be related to the 
presence of the extra insert in the C-terminal domain of Dim1 throughout the eukaryotes. 
Chimeric proteins were constructed by swapping the N- and C-terminal domains of 
Dim1p, KsgA, and MjDim1 and tested for functional complementation. We expected KD 
and/or MD, both with the C-terminal domain of Dim1p, to complement, however, they 
were not able to do so. Surprisingly, DM, with the N-terminal domain of Dim1p and the C-
terminal domain of MjDim1, could complement for Dim1p’s processing function. 
Sequence alignments show that MjDim1 also has an insert in the C-terminal domain and 
although it appears shorter than that of eukaryotic proteins, it may nevertheless be 
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sufficient for functional complementation. Even though there is no sequence similarity in 
the insert region of Dim1p and MjDim1, it is possible that the insert in MjDim1 forms a 
helix similar to that in Dim1p which is sufficient for making a vital interaction with 
another protein or RNA. 
             Some more information can also be inferred from the above results. There is a 
relatively good sequence and structural similarity in the N-terminal domain region of 
KsgA and Dim1p (Figures 11 and 16). Although the structure of MjDim1 is not available, 
its sequence shows good similarity with Dim1p and KsgA in the N-terminal domain. 
Despite the similarity, the failure of KD and MD to complement Dim1p function indicates 
that some feature(s) of the N-terminal domain of Dim1p are essential along with elements 
in the C-terminal domain. A striking feature is the extended N-terminal end in eukaryotic 
Dim1p relative to the bacterial and archaeal proteins; unfortunately, the structure of this 
region is not available in KsgA or human Dim1. The presence of this extension might be 
essential to Dim1p activity in some way. 
               In order to purify non-dimethylated 40S subunits and test if Dim1p could 
methylate them in vitro, we have constructed a strain, Y-E85A in which the pre-rRNA 
processing and dimethylation functions have been uncoupled (Figure 19c). Earlier, 
Lafontaine et al. have isolated a dim1-2 strain from a library of conditionally lethal alleles 
of DIM1 in which the pre-rRNA processing was not affected at the permissive temperature, 
but the dimethylation was blocked50. It has six random mutations scattered throughout the 
length of the protein and showed a slow growth phenotype at the non-permissive 
temperature. However, Y-E85A showed identical growth rates at all the temperatures 
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(Figure 25) resulting in the conclusion that temperature sensitivity of dim1-2 strain is due 
to the random mutation/s and not because of the loss of dimethyl groups. 
            Failure of Dim1p as well as KsgA and MjDim1 to methylate the mature 40S 
subunits in vitro was a little surprising to us because all of these proteins were able to 
methylate mature 30S subunits49. This could be due to one or more of the following 
reasons. The 30S subunits that were methylated by KsgA, Dim1p and MjDim1 were 
locked in a ‘translationally inactive’ confirmation which is achieved in low salt and Mg2+ 
concentration51. The methylation of 40S subunits was attempted in the same conditions, 
however, these conditions may not be optimal for 40S methylation because yeast 40S may 
not have a similar conformational dependence on Mg2+ concentration. Another reason 
could be a requirement for other factors. Dim1p is part of the 90S pre-ribosome and after 
its separation into a pre-60S and a pre-40S particle, the precursor of the small subunit has a 
less complex composition, but there are still trans-acting factors present along with the 20S 
pre-rRNA and small ribosomal subunit proteins21. It is possible that Dim1p requires the 
presence of other factors; a prominent candidate is Dim2p, which was shown to be 
required for A1, A2 cleavages and also for methylation carried out by Dim1p76. However, 
addition of Dim2p or cell lysate to the in vitro assays did not allow methylation by Dim1p. 
Another problem could be that Dim1p can recognize only a particular 40S precursor as its 
substrate for methylation. Processing of 20S pre-rRNA to 18S rRNA is considered to be 
the last event in 40S biogenesis, occurring after the dimethylation event, but the processing 
can still occur in the absence of dimethylation50,91. This processing might induce 
conformational changes in the 40S subunit which are not favorable for methylation.  
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 Previous work in our lab showed that conservation in the KsgA/Dim1 family, as 
well as in the small ribosomal subunit, is high enough that KsgA orthologs from all three 
domains can still recognize bacterial 30S as a substrate49. This work, conversely, shows 
that Dim1p and the ribosome biogenesis process have co-evolved, leading to a well 
defined function for Dim1p upstream of its methyl transfer reaction that cannot be 
complemented by the bacterial and archeal proteins. Although it is established that Dim1p 
and other factors are required for A1 and A2 processing, the details of their interactions 
with each other and with the rRNA is not known yet. Further studies of the interactions 
between these factors would help us in better understanding of the intricate steps of 
ribosome biogenesis. 
 
Materials and methods 
Plasmids  
DIM1 was amplified from pET15b-DIM1 as a XhoI-NheI fragment and subcloned 
into pESC-URA vector (Stratagene) to give pESC-URA-DIM1 which results in Dim1p with 
N-terminal myc epitope. This clone and all subsequent clones were confirmed by 
sequencing at Nucleic Acids Research Facilities, Virginia Commonwealth University. 
KsgA was amplified from pET15b-KsgA as a NotI-SpeI fragment with an 
exogenous NLS (nuclear localization signal – PPKKKRKV) and subcloned into pESC-
LEU vector (Stratagene) to give pESC-LEU-KsgA which results in KsgA with N-terminal 
NLS and C-terminal FLAG epitope. Similarly MjDim1 was amplified from pET15b-
MjDim1 as a NotI-SpeI fragment with the exogenous NLS and subcloned into pESC-LEU 
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vector to give pESC-LEU-MjDim1 which results in MjDim1 with N-terminal NLS and C-
terminal FLAG epitope. KsgA was also amplified as a BglII-PacI fragment (without 
exogenous NLS) and subcloned into pESC-LEU vector to give pESC-LEU-KsgA-2 which 
results in KsgA with N-terminal FLAG epitope. DIM1, KsgA, MjDim1 were also amplified 
as NotI-SpeI fragment (without exogenous NLS) and subcloned into pESC-LEU vector to 
give pESC-LEU-DIM1, pESC-LEU-KsgA-3, pESC-LEU-MjDim1-2 respectively, which 
results in respective protein with C-terminal FLAG epitope. As a control DIM1 was 
amplified from pET15b-DIM1 as a NotI-SpeI fragment with the exogenous NLS and 
subcloned into pESC-LEU vector to give pESC-LEU-DIM1-2 which results in Dim1p with 
N-terminal NLS and C-terminal FLAG epitope. 
Chimera plasmids  
The N-terminal and C-terminal domains of DIM1, KsgA, MjDim1 were amplified 
separately as NdeI-SalI and SalI-XhoI fragments. The amplicons were then digested with 
SalI and ligated as following. N-terminal domain of KsgA is ligated with C-terminal 
domain of DIM1 and MjDim1 to generate KD and KM chimeras respectively. N-terminal 
domain of DIM1is ligated with C-terminal domain of KsgA and MjDim1 to generate DK 
and DM chimeras respectively. N-terminal domain of MjDim1 is ligated with C-terminal 
domain of DIM1 and KsgA to generate MD and MK chimeras respectively. All the six 
chimeras were inserted into pET15b as an NdeI-XhoI fragment. DK and DM were again 
amplified as NotI-SpeI fragments and subcloned into pESC-LEU vector to give pESC-
LEU-DK, pESC-LEU-DM, which results in protein with C-terminal FLAG epitope. KD, 
KM, MD, MK were amplified as NotI-SpeI fragments (with exogenous NLS) and 
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subcloned into pESC-LEU vector to give pESC-LEU-MD, pESC-LEU-MK, pESC-LEU-
KD, pESC-LEU-KM, which results in respective protein with N-terminal NLS and C-
terminal FLAG epitope. (See Appendix (Table 5) for primer information)  
In vivo assay in bacteria 
The in vivo assay was carried out as described in chapter 3 (see Table 3 for pET15b 
constructs). 
Mutagenesis 
The E85A mutation in pESC-LEU-DIM1 was generated using QuikChange XL 
Site-Directed Mutagenesis Kit (Stratagene) and primers 5´-C GTA GTG GCA GTA GCA 
ATG GAT CCC AGA ATG G-3´ and 5´-C CAT TCT GGG ATC CAT TGC TAC TGC 
CAC TAC G-3´ to give pESC-LEU-dim1-E85A. 
Yeast Strains 
Standard S.cerevisiae growth and handling techniques were employed. Media were 
standard yeast extract/peptone supplemented with either glucose (YPD) or 2% galactose 
(YPGal) or minimal medium (0.67% YNB, appropriate aminoacids, 2% galactose) 
containing 200 mg/L Geneticin (G418). In order to maintain selective pressure for the 
plasmid/s, either uracil or leucine or both were dropped appropriately, from the minimal 
media. Transformation was carried out using LiOAc/PEG method136.  
         The yeast deletion clone (#21026) generated by the Saccharomyces Genome Deletion  
Project (http://www-sequence.stanford.edu/group/yeast_deletion_project/deletions3.html) 
was obtained from Invitrogen (catalog no. 95400). Y-21026 is a diploid strain, derived 
from BY4743, that is heterozygous for a DIM1 deletion (one chromosomal DIM1 copy is 
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replaced with the KanMX4 module). BY4743 is auxotrophic for histidine, leucine and 
uracil and hence the genotype of Y-21026 is MAT a/α his3Δ1/his3Δ1 leu2Δ0 /leu2Δ0 
lys2Δ0/LYS2 MET15/met15Δ0 ura3Δ0 /ura3Δ0 DIM1/dim1Δ0::KanMX4. This strain was 
transformed with pESC-URA-DIM1 and induced to sporulate.  Tetrads were dissected on 
synthetic medium lacking uracil to maintain selection for the plasmid.  Spore colonies that 
were Ura+ and geneticin-resistant were tested for mating type.  From these spores, a strain 
of the genotype, MATα his3Δ1 leu2Δ0 ura3Δ0 dim1Δ0::KanMX4 (pESC-URA-DIM1), 
labeled as Y26hα-URA-DIM1 was selected for further transformations. 
Complementation Assay  
Y26hα-URA-DIM1 was transformed again with a second plasmid, pESC-LEU-
DIM1, pESC-LEU-DIM1-2, pESC-LEU-KsgA, pESC-LEU-KsgA-2, pESC-LEU-KsgA-3, 
pESC-LEU-MjDim1, pESC-LEU-MjDim1-2, pESC-LEU(no insert) to give Y2P-DIM1, 
Y2P-DIM1-2, Y2P-KsgA, Y2P-KsgA-2, Y2P-KsgA-3, Y2P-MjDim1, Y2P-MjDim1-2, 
Y2P-LEU respectively.  
Y26hα-URA-DIM1 was also transformed with chimera plasmids, pESC-LEU-KD, 
pESC-LEU-DK, pESC-LEU-MD, pESC-LEU-DM, pESC-LEU-MK, pESC-LEU-KM and 
plasmid with mutant DIM1, pESC-LEU-dim1-E85A to give Y2P-KD, Y2P-DK, Y2P-MD, 
Y2P-DM, Y2P-MK, Y2P-KM and Y2P-E85A respectively. 
Fluoro-orotate resistant clones were selected on minimal medium (YNB, histidine, 
uracil, galactose) containing 1 g/L 5-Fluoro-orotic acid (5-FOA)135. Plates were incubated 
for 3 days at 30˚C. Y2P-DIM1, Y2P-DIM1-2, Y2P-DM, Y2P-E85A survived on 5-FOA, 
losing the first plasmid, pESC-URA-DIM1 and hence these 5-FOA resistant clones with 
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only the second plasmid were labeled Y-DIM1, Y-DIM1-2, Y-DM, Y-E85A respectively 
(Table 4).  
The plasmids in the yeast strains were confirmed by PCR followed by sequencing. 
Cell growth comparison between Y-DIM1 and Y-E85A 
Colonies of Y-DIM1 and Y-E85A were inoculated into 2ml of minimal medium 
and grown to an OD600 of 1.0. Dilutions (1x to 100x) of both strains were spotted on 
minimal media plates and incubated for 3 days at 25, 30, 37˚C and for 4 days at 18˚C 
(Figure 25). 
Immunofluorescence 
The immunofluorescence procedure was adapted from the methods described by 
Pringle et al.137. Cells were inoculated into 2ml of minimal medium and grown to an OD600 
of 1.0. The cells were fixed by adding 1/10 volume of 37% formaldehyde to the culture 
and incubating for 1 h at room temperature. The cells were then washed twice with 100 
mM phosphate buffer (pH 7.4) and once with SP buffer (1.2 M sorbitol, 20 mM potassium 
phosphate buffer, pH 7.4). Cell walls were digested with Zymolyase-20T (50µg/ml) in SP 
buffer containing 1µl/ml β-mercaptoethanol at 30˚C for 30 min. The spheroplasts were 
washed twice with SP buffer and resuspended in 200 µl of SP buffer. 20 µl of cell 
suspension was applied to multi-well Teflon-faced slides coated with poly-L-lysine, 
incubated for 10 min at RT and the excess suspension was aspirated out. Slides were 
immersed in methanol at -20˚C for 5 min. The wells were washed 10 times with 50 µl of 
1% BSA in PBS. The primary antibodies, Anti-FLAG M2 Monoclonal antibody from 
mouse (Sigma) and/or Anti-c-Myc antibody from rabbit (Sigma) were applied to each well 
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(15 µl of 200 fold dilution) and incubated at RT for 2 h. Slides were further washed 10 
times with 1% BSA in PBS. The secondary antibodies, Alexa Fluor 594 goat anti-mouse 
IgG (Invitrogen) and/or Alexa Fluor 488 goat anti-rabbit IgG (Invitrogen) were applied (15 
µl of 500-fold dilution) and incubated for 1 h at RT. The cells were washed 5 times with 
PBS and finally 15 µl of DAPI (100 ng/ml) was applied to each well and incubated for 30 
min in the dark. The cells were again washed 5 times with PBS, mounting medium was 
added and cover glasses were sealed with nail polish. Cells were observed under a Leica 
TCS-SP2 AOBS confocal laser scanning microscope. 
Purification of 40S subunits  
The 40S purification procedure was adapted from Maag et al.138. An overnight 
culture of Y-21026 cells in YPD medium was used to inoculate 1 liter of YPD medium 
(for wild type 40S) and an overnight culture of Y-E85A cells in minimal medium was used 
to inoculate 1 liter of YPGal medium (for non-dimethylated 40S). Cells were grown at 30 
˚C to an OD600 of 1.0 and harvested by centrifugation. After rinsing the cell pellets with 
water, they were resuspended in 40 ml of lysis buffer (100 mM potassium acetate, 20 mM 
Hepes-KOH (pH 7.6), 2.5 mM magnesium acetate, 1 mg/ml of heparin, 2 mM DTT and 
1mM PMSF). Cells were lysed by passing 3 times through an Avestin EmulsiFlex-C3 
homogenizer at 25,000 psi. The lysate was then clarified by centrifugation at 11,000 rpm 
for 20 min at 4 ˚C and recentrifugation of the supernatant at 14,500 rpm for 45 min at 4 ˚C. 
The supernatant was gently layered onto 2.5 ml of sucrose cushion (100 mM potassium 
acetate, 20 mM Hepes-KOH (pH 7.6), 2.5 mM magnesium acetate, 500 mM KCl, 1 M 
sucrose, 2 mM DTT) and ribosomes were pelleted by ultracentrifugation in a Beckman 
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70Ti rotor at 35,000 rpm for 20 h. The pellets (ribosomes) were resuspended in 3 ml of 
high-salt wash (100 mM potassium acetate, 20 mM Hepes-KOH (pH 7.6), 2.5 mM 
magnesium acetate, 500 mM KCl, 2 mM DTT) and stirred gently at 4 °C for 1 h. This 
solution was then layered again upon a sucrose cushion (1.5 ml suspension and 2.5 ml 
cushion per tube) and ribosomes were pelleted by ultracentrifugation at 35,000 rpm in a 
Beckman type 70Ti rotor for 20 h. The pelleted 80S ribosomes were resuspended in 3 ml 
of subunit separation buffer (50 mM Hepes-KOH (pH 7.4), 2 mM MgCl2, 500 mM KCl, 
2 mM DTT, 1 mM puromycin) and incubated on ice for 15 min, then at 37 °C for 10 min. 
A portion (1 ml) of this solution was then layered upon each of 3 sucrose gradients (36 ml; 
50 mM Hepes-KOH (pH 7.4), 5 mM MgCl2, 500 mM KCl, 2 mM DTT, 0.1 mM EDTA 
and 10%-30% (w/v) sucrose). After centrifugation for 17 h at 19,000 rpm and 4 °C in a 
Beckman SW28 rotor, gradients were fractionated. The 40 S and 60 S peaks were pooled 
separately, the 40S subunits were dialysed against buffer K (40 mM Tris (pH 7.4), 40 mM 
NH4Cl, 4 mM magnesium acetate, 6 mM 2-mercaptoethanol) and stored at −80 °C. 
For confirmation, the rRNA was isolated from both wild type and non-
dimethylated 40S subunits and primer extension was carried out on both using the primer, 
5´-TAA TGA TCC TTC CGC A-3´, which is complementary to the very end of 18S 
rRNA50,74. Primer extension was seen only in the non-dimethylated 18S and not in the wild 
type 18S (Figure 26).  
Western blot 
In order to confirm the absence of catalytically inactive dim1-E85A protein in the 
purified non-dimethylated 40S subunits, western blot was carried out. Approximately 30 
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pmol of wild-type and non-dimethylated 40S samples were boiled in protein cracking 
buffer and loaded on a SDS gel. As a positive control FLAG-BAP (Sigma) fusion protein 
was also loaded. After running the gel, proteins were transferred to a PVDF membrane. 
After blocking the membrane with 3% non-fat dry milk, it is incubated with mouse anti-
FLAG M2 antibody (Sigma) followed by anti-mouse IgG-HRP conjugate (sigma). Color 
was developed using 4-CN as the substrate. The dim1-E85A protein with a C-terminal 
Flag epitope (~38 kD) was not found in the 40S samples (Figure 27).  
Cloning of DIM2 
S. cerevisiae genomic DNA was obtained from Invitrogen (#40802). DIM2 was 
amplified as a NdeI-XhoI fragment and then inserted into pET15b vector which results in 
Dim2p with N-terminal His-tag. (See Appendix (Table 5) for primer information)  
Protein expression and purification 
Dim1p was purified as described in chapter 2. KsgA and MjDim1 were purified as 
described in chapter 3. For expression of Dim2p, the plasmid pET15b-DIM2 was 
transformed into Rosetta 2 (DE3) cells. The cells were grown at 37°C to an OD600 of 1.2 in 
the presence of ampicillin and chloramphenicol. Protein induction was carried out under 
mild conditions with 0.2 mM IPTG at 25°C and harvested after 4 h. Purification was 
carried out by affinity chromatography using a Ni2+-NTA Agarose column (Qiagen) and 
buffers had 50 mM NaH2PO4, 300 mM NaCl, 15% glycerol, 1 mM PMSF and imidazole 
(10 mM in lysis buffer, 20 mM in wash buffer 1, 50 mM in wash buffer 2 and 300 mM in 
elution buffer) at pH 8.0. The cell pellets were resuspended in lysis buffer and broken by 
passing through an Avestin EmulsiFlex-C3 homogenizer two times at 15,000 psi, and 
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centrifuged to remove cell debris. Cleared lysate was loaded onto the Ni2+ column, washed 
and then eluted. Initial studies showed that Dim2p undergoes degradation within a few 
days and it is assumed to be caused by a protease. The degradation decreased when the 
purification procedure was carried out at 4°C and by the addition of protease inhibitors to 
the buffers.  
Proteins were estimated to be >95% pure by SDS-PAGE analysis and their 
concentrations were measured using the Bradford Protein Assay (Bio-Rad). 
In vitro assay 
The in vitro assay was adapted from Poldermans et al. Non-dimethylated 30S 
subunits were purified as described in chapter 3. Reactions were performed in 50 μL 
volumes containing 40 mM Tris (pH 7.4), 40 mM NH4Cl, 4 mM MgOAc, 6 mM 2-
mercaptoethanol, 1 mM SAM with 0.02 mM 3H-methyl-SAM (780 cpm/pmol; MP 
Biomedicals), 10 pmol 40S/30S subunits, and 10 pmol enzyme/protein.  The reactions 
were incubated at 37˚C. After 2 h the entire reaction volume was deposited onto DE81 
filter paper (Whatman), washed twice with ice-cold 5% TCA, and rinsed briefly with 
ethanol. Filters were air-dried for 1 h, placed into scintillation fluid, and counted.  
            The in vitro assay in presence of cell lysate was carried out using the following 
procedure. An overnight culture of Y-DIM1 cells in minimal medium was used to 
inoculate 500 mL of YPGal medium and grown at 30 °C to an OD600 of 1.0. After rinsing 
the cell pellets with water, they were resuspended in 20 ml of lysis buffer (40 mM Tris-
HCl (pH 7.4), 40 mM NH4Cl, 4 mM MgOAc, 3 mM DTT and 1mM PMSF). Cells were 
lysed by passing 3 times through an Avestin EmulsiFlex-C3 homogenizer at 25,000 psi. 
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The lysate was then clarified by centrifugation at 15,000 rpm for 45 min at 4˚C followed 
by ultracentrifugation in a Beckman 70Ti rotor at 35,000 rpm for 20 h to separate the 
ribosomes. The supernatant was then mixed with 200 pmol 40S subunits (wild type and 
non-dimethylated), 200 pmol Dim1p, and 3H-SAM to a final volume of 500 μL.  The 
reactions were incubated at 37˚C for 2 h. The entire reaction volume was then layered upon 
sucrose gradient (36 ml; 50 mM Hepes-KOH (pH 7.4), 5 mM MgCl2, 500 mM KCl, 2 mM 
DTT, 0.1 mM EDTA and 10%-30% (w/v) sucrose). After centrifugation for 17 h at 
19,000 rpm and 4 °C in a Beckman SW28 rotor, gradients were fractionated. 360 μL of the 
fractions corresponding to the 40S peak was added into 3 mL of scintillation fluid and 
counted. 
 
 92 
 
 
CHAPTER 5: Conclusions and future work 
 
 The eukaryotic 18S rRNA dimethyltransferase, Dim1 is an essential factor required 
for the ribosome biogenesis. The importance of this enzyme family is emphasized by its 
universal conservation. Apart from the dimethylation of small subunit rRNA, the members 
of Dim1/KsgA family have diverged to carryout secondary functions in the cell, which in 
most cases are vital. In eukaryotes, Dim1 is essential for the earliest pre-rRNA processing 
events occurring in the nucleolus. Though bound to the pre-ribosomal particles, the 
dimethylation of small subunit rRNA is not carried out until the final stages of ribosome 
biogenesis. We have characterized the yeast dimethylase, Dim1p, and obtained significant 
information regarding its structural features necessary for the processing function. 
Eukaryotes have an extra helix in their C-terminal domain which is absent in the bacterial 
orthologs and partially present in archaeal orthologs. Our data suggests that along with this 
C-terminal insert, some features of the N-terminal domain are also necessary for the 
processing function of Dim1p. Similar characterization of N-terminal domain has to be 
carried out using our plasmid shuffling technique, to identify the essential regions on the 
domain. A striking feature is the extended N-terminal end in eukaryotic Dim1p relative to 
the bacterial and archaeal proteins; unfortunately, the structure of this region is not 
available in KsgA or human Dim1. We speculate that the presence of this extension might 
be essential to Dim1p activity in some way. 
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Surprisingly, the entire C-terminal domain of Dim1p could be replaced with that of 
MjDim1 without any effect on the cell survival or growth. Although appearing to be 
shorter than that of eukaryotic proteins, it is possible that the C-terminal domain of 
MjDim1 is nevertheless sufficient for functional complementation. Even though there is no 
sequence similarity in the insert region of Dim1p and MjDim1, it is possible that the insert 
in MjDim1 forms a helix similar to that in Dim1p which is sufficient for making a vital 
interaction with another protein or RNA. With this result, any attempts to characterize the 
C-terminal insert by point mutations may not be successful.  
Another possibility is that Dim1p might be associating with Dim2p with the help of 
C-terminal insert. One way to test this interaction is by yeast two hybrid screening. But 
there is a problem with such as experiment. Both Dim1p and Dim2p are part of the SSU 
processome complex which also has more than 70 factors, most of them shuttling between 
nucleus and cytoplasm. Both of them also interact76 with other factors which may interfere 
with yeast two hybrid screening. Physical methods of studying the association, such as 
surface plasmon resonance or size exclusion chromatography, can be used. However, the 
poor solubility profile of Dim1p renders such studies difficult.  
During the course of this project, we have also tried to crystallize Dim2p, although 
without any success yet. But if solved, the information would be very helpful in studying 
the association with Dim1p.    
Another current project in our lab, in collaboration with Dr.Gloria Culver’s lab, 
aims to study the binding site of KsgA on 30S subunit using directed hydroxyl radical 
probing experiments. It has been recently reported that KsgA interacts with small 
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ribosomal subunits near functional sites, including initiation factor 3 and 50S subunit 
binding sites139. Such studies could also be extended to Dim1p and 40S subunits. Since 
Dim1p methylates 20S pre-rRNA in vivo, the non-dimethylated pre-40S subunits would be 
the ideal substrate for such experiments. The same subunits could also be tested for in vitro 
methylation using Dim1p, KsgA, and MjDim1 as they were not able to methylate the non-
dimethylated mature 40S subunits containing 18S rRNA (chapter 4). The strain Y-E85A 
produces non-dimethylated but mature 40S subunits. Therefore, knocking out any one of 
the factors/ proteins required for cleavage D would result in the inhibition of 20S rRNA 
processing to 18S rRNA. Processing factors Nob1p, Fap7p and ribosomal protein Rps14p 
are implicated in 20S processing and depletion of any one of them in Y-E85A, would 
result in the production of non-dimethylated pre-40S subunits.  
The binding site of Dim1p on 40S would, most probably, be similar to that of KsgA 
on 30S subunit. This information would be helpful in identifying the binding site of other 
factors, most prominently Dim2p. Recent studies by many groups have identified the 
composition of many pre-ribosomal particles and the picture of the pre-rRNA processing/ 
assembly machinery that is emerging is one of great complexity and interactivity. 
However, very little or almost no information is available at the structural level. Dim1p is 
one of the core constituents of the SSU processome, and remains bound until the late 
cytoplasmic stages. Further structural characterization of Dim1p and other processome 
factors would enable us to understand the functional interactions between them and the 
dynamics of ribosome biogenesis at a closer level. 
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APPENDIX A 
Table 5: Primers used for cloning and chimera construction 
 Primers 
 
1. 
 
For 
 
Rev  
DIM1 - XhoI-NheI fragment for subcloning into pESC-URA vector   
      
5´- CGT CTG CTC GAG ATG GGA AAG GCT GCG - 3´ 
 
5´- CTG GGC GCT AGC TCA TGA AAA ATG GAT ACC AAC CTG G - 3´ 
 
2. 
 
For 
 
Rev 
DIM1 - NotI-SpeI fragment for subcloning into pESC-LEU vector 
 
5´- GCC ACT GCG GCC GCA TGG GAA AGG CTG CG - 3´ 
 
5´- CTG GAC ACT AGT GCT GAA AAA TGG ATA CCA ACC TGG - 3´ 
 
3. 
 
 
For 
 
 
Rev 
DIM1 - NotI-SpeI fragment with the exogenous NLS for subcloning into pESC-
LEU vector 
 
5´- CTG ACT GCG GCC GCA TGC CAC CAA AGA AGA AGA GAA AGG 
TTA TGG GAA AGG CTG CGA AAA AGA AG - 3´ 
 
5´- CTG GAC ACT AGT GCT GAA AAA TGG ATA CCA ACC TGG - 3´ 
 
4. 
 
 
For 
 
 
Rev 
KsgA - NotI-SpeI fragment with the exogenous NLS for subcloning into pESC-
LEU vector 
 
5´- CTG GAC GCG GCC GCA TGC CAC CAA AGA AGA AGA GAA AGG 
TTA TGA ATA ATC GAG TCC ACC - 3´ 
 
5´- GCA CTG ACT AGT GCA CTC TCC TGC AAA GGC GCG - 3´ 
 
5. 
 
For 
 
 Rev 
KsgA - BglII-PacI fragment for subcloning into pESC-LEU vector 
 
5´- CCA GCC AGA TCT ATA TGA ATA ATC GAG TCC ACC AGG GCC - 3´ 
 
5´- GCC TCG TTA ATT AAT TAA CTC TCC TGC AAA GGC GCG - 3´ 
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6. 
 
For 
 
Rev 
KsgA - NotI-SpeI fragment for subcloning into pESC-LEU vector 
 
5´- AGT CAG GCG GCC GCA TGA ATA ATC GAG TCC ACC AGG - 3´ 
 
5´- GCA CTG ACT AGT GCA CTC TCC TGC AAA GGC GCG - 3´ 
 
7. 
 
 
For 
 
 
Rev 
MjDim1 - NotI-SpeI fragment with the exogenous NLS for subcloning into 
pESC-LEU vector 
 
5´- CTG GAC GCG GCC GCA TGC CAC CAA AGA AGA AGA GAA AGG 
TTA TGT TCA AAC CAA AGA AAA AAT TAG GGC - 3´ 
 
5´- GCA CTG ACT AGT GCT AAC CTA CCC CTA TTT TGC AG - 3´ 
 
8. 
 
For 
 
 
Rev 
MjDim1 - NotI-SpeI fragment for subcloning into pESC-LEU vector 
 
5´- AGT CAG GCG GCC GCA TGT TCA AAC CAA AGA AAA AAT TAG 
GGC - 3´ 
 
5´- GCA CTG ACT AGT GCT AAC CTA CCC CTA TTT TGC AG - 3´ 
 
9. 
 
For 
 
Rev 
N-terminal domain of DIM1 - as NdeI-SalI fragment for chimera construction 
 
5´- CCG ACG CAT ATG GGA AAG GCT GCG - 3´  
 
5´- AGT CAG GTC GAC TTG CGG TCT TGG ATT TTT AAT CTC - 3´ 
 
10. 
 
For 
 
Rev 
C-terminal domain of DIM1 - as SalI-XhoI fragment for chimera construction 
 
5´- CAG AGT GTC GAC TAC AAC GAA TGG GAT GGT TTG - 3´  
 
5´- CCG GAT CCT CGA GTC ATG AAA AAT GGA TAC C - 3´  
 
11. 
 
For 
 
Rev 
N-terminal domain of KsgA - as NdeI-SalI fragment for chimera construction 
 
5´- AGT GAC CAT ATG AAT AAT CGA GTC CAC CAG G - 3´  
 
5´- AGT CAG GTC GAC CGG GTG AGG CAT CGT TGC - 3´  
 
12. 
 
For 
 
C-terminal domain of KsgA - as SalI-XhoI fragment for chimera construction 
 
5´- CAG AGT GTC GAC GTT CGT GTG TTG AGC CGC - 3´  
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Rev 5´- CAG AGT CTC GAG TTA ACT CTC CTG CAA AGG CGC G - 3´  
 
13. 
 
For 
 
Rev 
N-terminal domain of MjDim1 - as NdeI-SalI fragment for chimera construction 
 
5´- GCC GCA CCA TAT GTT CAA ACC AAA GAA AAA ATT AGG - 3´  
 
5´- AGT CAG GTC GAC GTG GTA TTT GCC TTT GTT AGG TT - 3´  
 
14. 
 
For 
 
 
Rev 
C-terminal domain of MjDim1 - as SalI-XhoI fragment for chimera construction 
 
5´- CAG AGT GTC GAC AAT GAA AAT TTC TTT GAT GAT TTT TTG 
AGA GC - 3´  
 
5´- GCT ACT CGA GCT ATA ACC TAC CCC TAT TTT GCA G - 3´  
 
15. 
 
For 
 
Rev 
KD - NdeI-XhoI fragment for cloning into pET15b vector 
 
5´- AGT GAC CAT ATG AAT AAT CGA GTC CAC CAG G - 3´ 
 
5´- CCG GAT CCT CGA GTC ATG AAA AAT GGA TAC C - 3´ 
 
16. 
 
For 
 
Rev 
DK - NdeI-XhoI fragment for cloning into pET15b vector 
 
5´- CCG ACG CAT ATG GGA AAG GCT GCG - 3´  
 
5´- CAG AGT CTC GAG TTA ACT CTC CTG CAA AGG CGC G - 3´ 
 
17. 
 
For 
 
Rev 
MD - NdeI-XhoI fragment for cloning into pET15b vector 
 
5´- GCC GCA CCA TAT GTT CAA ACC AAA GAA AAA ATT AGG - 3´ 
 
5´- CCG GAT CCT CGA GTC ATG AAA AAT GGA TAC C - 3´ 
 
18. 
 
For 
 
Rev 
DM - NdeI-XhoI fragment for cloning into pET15b vector 
 
5´- CCG ACG CAT ATG GGA AAG GCT GCG - 3´  
 
5´- GCT ACT CGA GCT ATA ACC TAC CCC TAT TTT GCA G - 3´ 
 
19. 
 
For 
 
MK - NdeI-XhoI fragment for cloning into pET15b vector 
 
5´- GCC GCA CCA TAT GTT CAA ACC AAA GAA AAA ATT AGG - 3´ 
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Rev 5´- CAG AGT CTC GAG TTA ACT CTC CTG CAA AGG CGC G - 3´ 
 
20. 
 
For 
 
Rev 
KM - NdeI-XhoI fragment for cloning into pET15b vector 
 
5´- AGT GAC CAT ATG AAT AAT CGA GTC CAC CAG G - 3´ 
 
5´- GCT ACT CGA GCT ATA ACC TAC CCC TAT TTT GCA G - 3´ 
 
21. 
 
 
For 
 
 
Rev 
KD - NotI-SpeI fragment with the exogenous NLS for subcloning into pESC-LEU 
vector 
 
5´- CTG GAC GCG GCC GCA TGC CAC CAA AGA AGA AGA GAA AGG 
TTA TGA ATA ATC GAG TCC ACC - 3´ 
 
5´- CTG GAC ACT AGT GCT GAA AAA TGG ATA CCA ACC TGG - 3´ 
 
22. 
 
For 
 
Rev 
DK - NotI-SpeI fragment for subcloning into pESC-LEU vector 
 
5´- GCC ACT GCG GCC GCA TGG GAA AGG CTG CG - 3´ 
 
5´- GCA CTG ACT AGT GCA CTC TCC TGC AAA GGC GCG - 3´ 
 
23. 
 
 
For 
 
 
Rev 
MD - NotI-SpeI fragment with the exogenous NLS for subcloning into pESC-
LEU vector 
 
5´- CTG GAC GCG GCC GCA TGC CAC CAA AGA AGA AGA GAA AGG 
TTA TGT TCA AAC CAA AGA AAA AAT TAG GGC - 3´ 
 
5´- CTG GAC ACT AGT GCT GAA AAA TGG ATA CCA ACC TGG - 3´ 
 
24. 
 
For 
 
Rev 
DM - NotI-SpeI fragment for subcloning into pESC-LEU vector 
 
5´- GCC ACT GCG GCC GCA TGG GAA AGG CTG CG - 3´ 
 
5´- GCA CTG ACT AGT GCT AAC CTA CCC CTA TTT TGC AG - 3´ 
 
25. 
 
 
For 
 
 
Rev 
MK - NotI-SpeI fragment with the exogenous NLS for subcloning into pESC-
LEU vector 
 
5´- CTG GAC GCG GCC GCA TGC CAC CAA AGA AGA AGA GAA AGG 
TTA TGT TCA AAC CAA AGA AAA AAT TAG GGC - 3´ 
 
5´- GCA CTG ACT AGT GCA CTC TCC TGC AAA GGC GCG - 3´ 
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26. 
 
 
For 
 
 
Rev 
KM - NotI-SpeI fragment with the exogenous NLS for subcloning into pESC-
LEU vector 
 
5´- CTG GAC GCG GCC GCA TGC CAC CAA AGA AGA AGA GAA AGG 
TTA TGA ATA ATC GAG TCC ACC - 3´ 
 
5´- GCA CTG ACT AGT GCT AAC CTA CCC CTA TTT TGC AG - 3´ 
 
27. 
 
For 
 
Rev 
DIM1 - E85A mutation in pESC-LEU-DIM1  
 
5´-C GTA GTG GCA GTA GCA ATG GAT CCC AGA ATG G-3´  
 
5´-C CAT TCT GGG ATC CAT TGC TAC TGC CAC TAC G-3´ 
 
28. 
 
For 
 
 
Rev 
DIM2 - NdeI-XhoI fragment for cloning into pET15b vector 
 
5´- CCG ACG CAT ATG GTT GCG CCT ACT GCT TTG AAA AAG GCT 
ACT G - 3´ 
 
5´- GCA GCG CTC GAG TTA GTA GCG TTC TTT TAA TCT AGA TGC 
AAC GGT ACG - 3´ 
 
29. 
 
For 
 
Rev 
DIM1 - SmaI-XhoI fragment for cloning into pET44a vector 
 
5´- GCG GTA GCA TGG GAA AGG CTG CG - 3´ 
 
5´- CCG GAT CCT CGA GTC ATG AAA AAT GGA TAC C - 3´ 
 
30. 
 
For 
 
Rev 
 
DIM1 - EcoRI-XbaI fragment for cloning into pPICZαA vector 
 
5´- ACC GAA TTC ATG GGA AAG GCT GCG - 3´ 
 
5´- GCG TCT AGA GCT GAA AAA TGG ATA CCA ACC - 3´ 
 
31. 
 
 
For 
 
Rev 
 
N-terminal domain of DIM1 (DIM1N) - as NdeI-XhoI fragment for cloning into 
pET21c vector 
 
5´- CCG ACG CAT ATG GGA AAG GCT GCG - 3´  
 
5´- GG CTC GAG TTG CGG TCT TGG A - 3´ 
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APPENDIX B 
 
 
                        
                
Figure 28: Subcellular localization of KsgA. (a) the nuclei were stained blue with DAPI; 
(b) the protein is stained red with anti-FLAG antibody;  (c) shows the overlay of the 
nucleus and protein; (d) shows the DIC image. 
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Figure 29: Subcellular localization of the chimera protein, KD. (a) the nuclei were stained 
blue with DAPI; (b) the protein is stained red with anti-FLAG antibody;  (c) shows the 
overlay of the nucleus and protein; (d) shows the DIC image. 
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Figure 30: Subcellular localization of the chimera protein, DK. (a) the nuclei were stained 
blue with DAPI; (b) the protein is stained red with anti-FLAG antibody;  (c) shows the 
overlay of the nucleus and protein; (d) shows the DIC image. 
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Figure 31: Subcellular localization of the chimera protein, MK. (a) the nuclei were stained 
blue with DAPI; (b) the protein is stained red with anti-FLAG antibody;  (c) shows the 
overlay of the nucleus and protein; (d) shows the DIC image. 
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Figure 32: Subcellular localization of the chimera protein, KM. (a) the nuclei were stained 
blue with DAPI; (b) the protein is stained red with anti-FLAG antibody;  (c) shows the 
overlay of the nucleus and protein; (d) shows the DIC image. 
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